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Summary 
In development, wound healing and cancer metastasis vertebrate cells move through 3D interstitial 
matrix, responding to chemical and physical guidance cues. Protrusion at the cell front has been 
extensively studied, but the retraction phase of the migration cycle is not well understood. Here we 
show that fast moving cells guided by matrix cues establish positive feedback control of rear retraction 
by sensing membrane tension. We reveal a mechanism of rear retraction in 3D-matrix and durotaxis 
controlled by caveolae, which form in response to low membrane tension at the cell rear. Caveolae 
activate RhoA-ROCK1/PKN2 signalling via the RhoA-GEF Ect2, to control local F-actin organisation and 
contractility in this subcellular region and promote translocation of the cell rear. A positive feedback 
loop between cytoskeletal signalling and membrane tension leads to rapid retraction to complete the 
migration cycle in fast moving cells, providing directional memory to drive persistent cell migration in 
complex matrices. 
Introduction 
Cell migration is a fundamental process that underpins development, health and disease, and is 
characterised by a cycle of protrusion of the front and retraction of the rear1. In 3D matrix, cells move 
both individually and collectively2, and in cancer epithelial-mesenchymal transition (EMT) drives the 
dissemination of elongated single cells to form distant metastases even at very early stages in tumour 
development3. Whilst the mechanisms that govern protrusion are well characterised4, how retraction 
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of the cell rear is controlled to complete the migration cycle is still under debate5. Contractility driven 
by the action of non-muscle myosin II (NMII) on actin filaments is key for the generation of force 
required to actively retract the rear, and RhoGTPase signalling (in particular RhoA) is critical in 
determining NMIIA/B activity6. However, the mechanisms that control rear retraction in restrictive 
3D-matrix such as the interstitial fibrillar matrix environment encountered by metastatic cancer cells 
in vertebrates is not well understood.   
The plasma membrane is the physical barrier between intracellular and extracellular environments, 
and plays an important role in cell migration by both organising signalling and by exerting force 
(tension) on the underlying cytoskeleton7–9. Membrane tension resists membrane deformation, and 
is established in cells by the in plane tension in the lipid bilayer and membrane to cortex attachment9.  
Membrane tension was thought to propagate rapidly across cells, but recent evidence indicates that 
the cytoskeleton plays a role in resisting membrane flow10, allowing cells to establish differential 
membrane tension across their surface. Membrane tension has recently been shown to be a 
mechanical signal that regulates formation of focal adhesion complexes11 and the organisation of actin 
networks12 at the leading edge of migrating cells on 2D substrates. Biophysical models have suggested 
that membrane tension at the cell rear might promote retraction by exerting force13, however 
experimental evidence suggests that membrane tension is lower at the rear of migrating fish 
keratocytes in 2D14. In addition, the movement of membrane through endocytic traffic has been 
postulated to play an important role in gathering membrane from the cell rear for reutilisation at the 
front15. We set out to determine how the cell rear is actively retracted in mammalian cells moving 
within physiological 3D matrix, focusing on the dynamics of the plasma membrane in this subcellular 
region.  
Results 
Rear retraction in 3D matrix and durotaxis is a fast dynamic process 
Invasive cancer cells moving within fibrillar collagen and fibronectin 3D cell-derived matrix (CDM)16,17 
followed the topology of fibrils with defined lamellipodial and filopodial protrusions at the cell 
front18,19 (Figure 1A; S1A), similar to on 2D substrates. The retracting rear region of the cell was 
rounded and rapidly translocated with few small retraction fibres, and adhesion complexes or long 
retraction cables were rarely observed here (Figure 1A; S1G; Movie S1). In the absence of a 
chemotactic gradient, we hypothesised that the direction of migration up or down bundles of matrix 
fibrils could be determined by the physical properties of the matrix. Indeed, atomic-force microscopy 
(AFM) revealed an increase in matrix rigidity directly in front of moving cells (Figure 1A), suggesting 
strain stiffening of matrix by moving cells20 could maintain or generate polarity to guide the direction 
of cell migration. Local softening of the matrix with magnetic trypsin-coated beads21 (which did not 
destroy matrix architecture, Figure S1B) established a gradient of rigidity up to 2mm from the targeted 
area (Figure 1B), and within this gradient region the direction of cell migration over several hours could 
be changed from random such that cells orientated and moved toward stiffer matrix at a similar rate 
to cells in untreated matrix (Figure 1B; Movie S1). On 2D substrates, cells responded to a steep 
gradient of rigidity (>30kPa/mm; Figure 1C) by moving towards the stiffer substrate with a similar 
rounded and rapidly moving rear that orientated toward the soft substrate (Figure 1C; S1C; Movie S1). 
These data indicate that cells in 3D-matrix follow mechanical cues, and share morphology with cells 
migrating in 2D durotactic gradients. 
A front-rear membrane tension differential in fast moving cells 
Analysis of membrane dynamics at the rear of rapidly moving cells in 3D-matrix suggested that over 
the timescale of rapid retraction the plasma membrane accumulated, but significant internalisation 
of labelled membrane was not observed (Figure S1D-E; Movie S2). Membrane accumulation could 
result in lower plasma membrane tension9, and we therefore assessed membrane tension by pulling 
membrane tethers at the cell front and rear11,14. Tethers were extracted using an optical trap and the 
restoring force on the trap was used as a readout of effective membrane tension, which depends on 
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the in plane tension and the level of attachment between the membrane and the underlying 
cytoskeleton9. We found that there was no significant difference in membrane tension at the cell front 
versus the cell rear in cells migrating on uniform stiff substrates or on glass (Figure 1D-E; S1F). 
However, in durotactic cells migrating toward stiffer substrate in a 2D rigidity gradient, membrane 
tension was significantly lower at the cell rear compared to the front (Figure 1D-E; S1F), suggesting 
that durotactic cells show front rear polarity through establishment of a membrane tension 
differential. 
In order to analyse membrane tension in cells within a 3D-matrix (and therefore inaccessible via 
optical trapping) we used Flipper-TR, a small molecule that intercalates into membranes and indicates 
in-plane membrane tension through changes in fluorescence lifetime of the probe22. Live cells showed 
a striking decrease in fluorescence lifetime specifically at the cell rear (Figure 1F), suggesting that in-
plane membrane tension is significantly lower at the rear of cells moving in 3D matrix. 
Caveolae accumulate at the rear of fast moving cells 
Caveolae are plasma membrane invaginations that can act as a route for endocytosis, but they also 
play a mechanoprotective role by flattening in response to increased membrane tension23–27. 
Caveolin-1 (a major component of caveolae) and caveolae have previously been shown to polarise at 
the rear of migrating endothelial cells, fibroblasts and neurons28–30, although in metastatic cancer cells 
this is not always observed31. We hypothesised that caveolae may form as a consequence of the 
decrease in membrane tension at the cell rear. We observed caveolin-1 localised to the rear of fast 
moving cancer cells in 3D matrix (Figure S1G; S2A). Cavin-1, a critical structural component of 
caveolae24, was also found to accumulate around the rear of fast moving cancer cells in 3D matrix 
(Figure 2A; S2B-C) and co-localised with caveolin-1 (Figure 2A). Caveolin-1 and cavin-1 containing 
structures appeared close to the plasma membrane around the rear of cells moving in 3D and on 2D 
rigidity gradients (Figure 2A-C; S2D-H) and in cancer cells escaping spheroids in 3D-matrix (which share 
the elongated morphology of cells moving in 3D CDM; Figure 2D-F). Fibroblasts (MEFs and TIFs) were 
on average slow moving, elongated and poorly polarised in 3D matrix (Figure S2I-K) and on 2D rigidity 
gradients were not persistently motile, and did not show a membrane tension differential (Figure S2L). 
However, a proportion of fibroblasts migrated rapidly in 3D matrix with similar morphology to cancer 
cells and showed cavin-1 accumulation at the cell rear (Figure S2M-O; Movie S3). 
Cavin-1 also colocalised closely with EHD2, which stabilises caveolae at the plasma membrane32 
(Figure 2G), which suggests that relatively stable caveolae form at the rear of fast moving cells.  By 
correlating light microscopy with serial block face scanning electron microscopy (EM), we observed 
structures that resembled caveolae where caveolin-1 accumulated at the rear of moving cells, but not 
in other regions of the cells (e.g. perinuclear accumulation of internal caveolin-1; Figure S2P; Movie 
S4). We correlated light microscopy with higher resolution serial transmission EM (sTEM) and acquired 
stitched high-resolution TEM images of serial sections (every 100 nm, 65 sections, 6.5 m) to fully 
reconstruct migrating cells at nanoscale. TEM demonstrated that caveolae were enriched at the 
membrane at the rear of the cells in 3D matrix (Figure 2H). Segmentation of caveolae and caveolae-
associated vesicles at the rear of the cell revealed numerous individual and multilobed structures, and 
interestingly many of these possessed a clear ‘neck’ connected to the plasma membrane33. These data 
indicate that fast moving cells in 3D matrix accumulate caveolae at the rear, which could act as a vast 
membrane reservoir to collect accumulating membrane. 
Caveolae respond to low membrane tension to form at the cell rear 
Because caveolae formation is sensitive to membrane tension23, we used osmotic shock to acutely 
manipulate membrane tension11,23. Introduction of 50% hypo-osmotic medium into the imaging 
chamber opposed caveolae formation at the rear of cells in 3D matrix and in durotactic gradients, 
whilst internal mCherry-caveolin-1 in the perinuclear region was relatively unchanged, and forward 
movement of the rear was suppressed (Figure 3A-B; S3A-C; Movie S5). Returning cells to isotonic 
medium was sufficient to allow re-establishment of caveolae and rear retraction (Figure 3A-B; Movie 
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S5). Live imaging of mCherry-caveolin-1 in cells transferred from hypo-osmotic to isotonic medium 
demonstrated a rapid increase in the average fluorescence intensity of caveolin-1 structures around 
the cell rear concomitant with re-establishment of rear retraction, whilst the average intensity of 
caveolin-1 structures in the rest of the cell remained relatively constant (Figure 3C).  This indicates 
that caveolin-1 accumulation at the cell rear does not coincide with removal of caveolin-1 structures 
from other regions of the cell, rather that caveolin-1 accumulation is perhaps consistent with diffusion 
in the plasma membrane giving rise to higher average intensity structures. These data suggest 
caveolae are dynamic structures that can form spontaneously in response to low membrane tension 
at the rear, rather than being trafficked from other regions of the cell. 
In order to locally influence membrane tension in live cells, we expressed constitutively active (CA) 
ezrin mutant (ezrin T567D-GFP; relieves autoinhibition34) to promote membrane-cortex attachment 
and increase membrane tension35,36, and took advantage of the finding that this protein accumulates 
specifically around the rear of cells in 3D matrix (Figure 3D). CA-ezrin significantly abrogated the rate 
of rear retraction, to a greater extent than wild type ezrin (Figure 3D), and prevented cavin-1 
accumulation at the cell rear (Figure 3E). Furthermore, this mutant opposed the membrane tension 
differential observed in cells moving on 2D durotactic gradients (Figure 3F). Taken together, these 
data show that caveolae respond to a local decrease in membrane tension to form and become 
stabilised at the cell rear, and promote retraction of the migrating cell rear. 
Caveolae activate RhoA at the cell rear to promote retraction 
Caveolin-1 has been implicated in the regulation of RhoGTPases, cell polarity, cell migration and 
wound healing in the mouse dermis24,37,38, but the function of caveolae at the rear of migrating cells 
or role of caveolae/caveolin-1 in rear retraction is not known. In 3D matrix, knockdown of caveolin-1 
with either of two independent siRNA oligonucleotides significantly reduced the speed of migration 
over long timelapses and increased cell length (Figure S4A-D). Caveolin-1 knockdown had little impact 
on the ability of cells to generate and extend protrusions, but reduced the distance that the cell rear 
translocated over a 5 minute time period (Figure 4A, Figure S4E-F), demonstrating a clear retraction 
defect in 3D migration. EHD2 regulates the stability/maturation of caveolae at the plasma 
membrane32, and EHD2 knockdown resulted in loss of caveolin-1 localisation at the rear of cells 
moving in 3D matrix (Figure S4G). EHD2 knockdown cells showed a decreased rate of migration over 
long time courses, and cells were elongated and showed defective cell rear translocation (Figure S4G-
H), supporting a role for caveolae in rear retraction. 
Because caveolae have previously been implicated in the regulation of RhoGTPases24, we 
hypothesised that caveolae could play a role in the activation of RhoA to organise the actin 
cytoskeleton and mediate rear retraction. Using a location biosensor to report on active RhoA 
localisation (GFP-AHPH39,40), we observed a punctate distribution of active RhoA concentrated around 
the retracting rear of cells moving in 3D matrix and in durotaxis (Figure S4I-J). Active RhoA and 
caveolin-1 co-distributed at the rear of cells moving in 3D matrix and durotactic gradients (Figure 4B; 
S4K; Movie S8) and high resolution imaging revealed partial co-localisation (Figure 4C), suggesting that 
caveolae and active RhoA localise in close proximity at the rear of migrating cells. Next, we used a 
RhoA FRET biosensor to show that RhoA activity, as expected, was elevated at the rear of cells 
migrating in 3D matrix, but knockdown of caveolin-1 significantly abrogated RhoA activation at the 
cell rear (Figure 4D). Increasing membrane tension with osmotic shock (which impairs caveolae 
formation; Figure 3A-C) similarly impaired the activation of RhoA (Figure 4E, S4L), suggesting that 
caveolae sense and respond to low membrane tension at the cell rear and activate RhoA in this 
subcellular region. 
RhoA coordinates rear retraction by organising F-actin at the cell rear 
RhoA plays a key role in regulating actomyosin contractility and retraction of the rear in migrating cells 
in 2D1, and we found that RhoA knockdown cells showed a clear defect in rear retraction in 3D 
migration41 (Figure S4M). Having identified a rear retraction defect associated with a caveolae-RhoA 
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pathway, we analysed how this pathway influenced the organisation of actin in cells migrating in 3D. 
Knockdown of caveolin-1 had very little effect on the intensity of F-actin towards the front of cells 
moving in 3D matrix, but strikingly decreased F-actin intensity at the rear (Figure 4F). Similarly, Y27632, 
a selective inhibitor of the ROCK and PKN RhoA effector kinases, decreased F-actin intensity in the rear 
portion of the cell (Figure S4O). Knockdown of RhoA and individual effector kinases ROCK1 and PKN2 
(PRK2) selectively abrogated migration speed, F-actin intensity and organisation at the cell rear (Figure 
4G-J, S4N-Q). Strikingly, high resolution imaging revealed that F-actin was organised into cables 
oriented along the front- rear axis at the cell rear which were lost upon ROCK1 and PKN2 (but not 
ROCK2, PKN1 or PKN3) depletion (Figure 4H, S4Q). Inhibition of Rho effector kinases42 or knockdown 
of caveolin-1 significantly abrogated rear retraction independently, but had no additive effect (Figure 
4K), suggesting that caveolin-1 and RhoA effector kinases form part of the same regulatory pathway. 
These data indicate that caveolae activate RhoA-ROCK1/PKN2 signalling modules which organise F-
actin specifically at the cell rear and promote actin organisation and contractility. 
Ect2 is recruited by caveolae to activate RhoA and promote rear retraction 
Caveolae have been linked to RhoA activity, at least in part by preventing RhoA inactivation by 
p190RhoGAP38. However, GEFs that specifically activate RhoA in this context are not known. By using 
a GFP-trap/mass spectrometry approach to identify GFP-RhoA binding proteins, we uncovered 6 
candidates potentially involved in RhoGTPase activation, the GEFs Ect2, Vav2, ARHGEF2 (GEF-H1), 
PLEKHG5, DOCK1 and its co-factor ELMO2 (Figure S5A and data not shown). Knockdown of these 
candidates revealed that 4 (Ect-2, Vav2, ARHGEF2 and PLEKHG5) played a role in motility in 3D matrix 
(Figure S5A-C). Whilst knockdown of Ect2 and PLEKHG5 resulted in an elongated morphology 
consistent with a defect in retraction (Figure S5B-D), knockdown of Ect2 alone caused a clear defect 
in rear retraction in cells moving on 3D matrix (Figure 5A). Moreover, knockdown of Ect2, but not Vav2 
or PLEKHG5, significantly reduced the activation of RhoA at the rear of cells moving in 3D matrix 
(Figure 5B), suggesting that Ect2 acts as the main GEF that activates RhoA to mediate rear retraction. 
Ect2 is targeted to the membrane after nuclear envelope breakdown to activate RhoA and execute 
cytokinesis43–45, and although it is reported to localise predominantly to the nucleus in interphase cells, 
Ect2 can also activate RhoA to stabilise cell:cell junctions40,46. In fast moving cells in 3D-matrix, Ect2 
was distributed between the nucleus and cytoplasm, but accumulated at the cell rear where it 
colocalised with cavin-1 (Figure 5C). Knockdown of caveolin-1, however, suppressed the accumulation 
of Ect2 at the cell rear without markedly influencing the nuclear-cytoplasmic balance (Figure 5D). This 
suggests that Ect2 is specifically recruited to the cell rear by caveolae to activate RhoA and promote 
rear retraction. 
Computational models describe persistent movement in mechanically guided cell migration 
In order to gain further insight into the dynamic signalling and mechanical events leading to rear 
retraction of cells within durotactic gradients and upon strain-stiffening of 3D-ECM, we built a 
mathematical model based on ordinary differential equations (ODEs) to describe the signalling that 
controls rear retraction. This model was based upon our key findings as outlined above (Figures 1-5) 
and literature (see methods section for detailed breakdown of all reactions/nodes and parameters). 
This models the rear domain and considers the interplay between signalling dynamics and mechanical 
inputs; because we observe caveolae formation in durotactic migration, polarised substrate stiffness 
is the only external input, transduced from cell-matrix adhesion complexes at the cell front by 
actomyosin to initiate forwards translocation of the cell and establish a front-rear membrane tension 
differential (Figure 6A, B). Our model recapitulates signalling occurring at the cell rear in response to 
mechanical inputs, leading to F-actin organisation and phosphorylation of NMII via ROCK1/PKN2 
(Figure 6A, B). We explicitly modelled an initially non-homogenous ‘polarised substrate stiffness’ (set 
to 100%) to mimic the strain-stiffened state of matrix in front of cells moving in 3D-matrix and the 
substrate encountered by cells on 2D rigidity gradients, while all other (non-inhibitory) variables were 
set as initially zero. Simulations of this non-homogenous modelled domain showed the output ‘rear 
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retraction’ (conceptualised as directional rear movement towards initially stiffer areas, such that a 
high value corresponds to persistent, fast movement and a low value corresponds to slow migration 
and/or random, non-persistent directionality) to rapidly increase to a high steady state, while without 
the external polarised substrate input (uniform throughout), rear retraction levels were negligible 
(Figure 6C). Sensitivity analysis (Figure S6A) revealed critical model parameters, and halving or 
doubling critical parameters had little effect on modelled outputs (Figure S6B), suggesting that the 
model and its overall network topology was robust. Interestingly, if the cell was simulated to transition 
from a polarised to a uniform substrate, the rear retraction output was near identical to the 
unperturbed polarised case, while if a cell instead transitioned from a uniform to a polarised substrate 
then the rear would begin retracting accordingly after the transition (Figure 6C). This indicates that 
once a rear begins to rapidly retract it can continue to do so independently of the external polarisation 
conditions. This may reflect the ability of cells to move persistently in disordered 3D matrix and 
suggests that rear retraction could act as a directional memory to conserve persistent migration in 
complex matrix. 
Simulations of this model were in close agreement with our experimental findings: independent 
individual reduction of caveolae (knockdown of caveolin-1, EHD2) or RhoA (corresponding to 
experimental knockdown efficiency) severely reduced F-actin alignment and rear retraction ‘speed’ 
(Figure 6D) in silico. We could also mimic the reversible osmotic shock protocol, whereby increasing 
the transition from low to high membrane tension reduced caveolae formation and halted rear 
retraction, while returning the membrane tension to a decreased state rapidly restored rear caveolae 
accumulation and efficient retraction (Figure 6E). This gave confidence in the topology and structure 
of our model and suggested that it could serve as a predictive tool.  
Positive feedback reinforcement of RhoA-mediated contractility 
During model construction, a potential feedback loop became apparent. We theorised that a gradient 
of stiffness, transduced by actomyosin contractility generated via integrin-mediated adhesion, would 
lead to decreased rear membrane tension and formation of caveolae. Because caveolae formation at 
the cell rear promotes RhoA activation, we predicted a positive feedback loop between RhoA-
mediated contractility within the rear domain and caveolae formation via a further decrease in 
membrane tension (Figure 5A, B). Simulation showed that this feedback loop was a plausible feature 
of the model, and predicted that it could be broken (and caveolae formation arrested) by inhibition of 
Rho effector kinases (simulated as an increase in both ROCK1 and PKN2 inactivation rates, in silico 
Y27632 treatment; Figure 6F). Similarly, increasing F-actin turnover, either globally or locally, was 
predicted to prevent further formation of caveolae and to halt forward movement of the rear (Figure 
6G, H). 
In order to experimentally verify positive feedback between RhoA signalling and caveolae formation, 
we first treated cells with Y27632 to inhibit Rho-effector kinases. mCherry-caveolin-1 was rapidly 
redistributed from the rear of cells migrating in 3D matrix within 10 mins (Figure 7A-B; Movie S6), 
suggesting that signalling downstream of RhoA through ROCK1/PKN2 is required to maintain positive 
feedback. Similarly, RhoA knockdown cells failed to recruit mCherry-caveolin-1 to the cell rear in 3D 
matrix (Figure S7A-B). Knockdown of Ect2, RhoA or ROCK1 suppressed the recruitment of endogenous 
caveolin-1/cavin-1 to the cell rear in 3D matrix (Figure 7C-E; S7C-D), indicating that RhoA signalling is 
required to form caveolae at the retracting rear. Furthermore, membrane tension at the rear of cells 
moving in 3D-matrix was increased by inhibition of Rho-effector kinases (Figure 7G), suggesting that 
maintenance of low membrane tension requires the RhoA signalling cascade.  
Cytochalasin D (CytoD), an agent that can both inhibit actin polymerisation and promote 
depolymerisation47, was found to disrupt F-actin and rear caveolae in cells in 3D matrix (Figure S7E). 
In order to more locally influence F-actin turnover, we used a caged form of CytoD (Nvoc-CytoD48; 
Figure S7F) and analysed the effect of such acute intervention on the formation of caveolae at the rear 
of cells actively migrating in 3D matrix.  Initiating uncaging to release the active compound led to a 
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reduction in F-actin intensity at the rear and the concomitant redistribution of mCherry-caveolin-1 
(Figure 7H; S7G; Movie S7). These data confirm that rear retraction is a dynamic process underpinned 
by a positive feedback loop centred on the formation of caveolae to amplify RhoA activity at the rear 
of migrating cells and effect rear retraction. 
Discussion 
Here we show that cells moving in fibrillar 3D matrix and on durotactic gradients establish a front- 
rear membrane tension differential, and low membrane tension is sensed at the cell rear by caveolae.  
Cells follow rigidity gradients on 2D (Figure 1C) and in 3D-matrix (Figure 1B), and in unperturbed 3D-
matrix cells strain-stiffen the extracellular matrix in front (Figure 1A), to establish front-rear polarity 
and in this context active translocation of the rear occurs at >1m/min. This rapid retraction is 
mediated by caveolae, which promote contractility signalling by recruiting the RhoAGEF Ect2 to 
activate RhoA and its effectors ROCK1 and PKN2. Positive feedback could then be established by 
actomyosin contractility to promote further reduction in membrane tension, caveolae formation and 
hyperactivation of RhoA. This mechanism explains rapid retraction of the migrating cell rear, allowing 
single cells to move fast and persistently in 3D matrix and on gradients of rigidity.  
Rear retraction in migrating cells is known to require RhoA-mediated signalling to the contractile actin 
cytoskeleton1, and in 2D migration some mechanistic detail has emerged revealing how RhoA is 
regulated and how NMII isoforms organise front rear polarity49–51. RhoA activity has also been 
implicated in driving rearward cortical actin and membrane flow to control the migration of amoeboid 
cells which lack strong cell-matrix interactions52,53. Our study reveals how membrane tension acts as 
a key mechanical feature of cells moving in gradients of rigidity, to allow formation of caveolae, which 
in turn coordinate activation of the contractile cytoskeleton. Cells in 3D matrix can strain stiffen their 
local environment20 to create or amplify any differences in rigidity that might exist. A gradient of 
rigidity could generate a membrane tension differential through adhesion complexes at the front of 
polarised cells, which would encounter higher resistive force resulting in net forward movement of 
the contractile actin cytoskeleton and lower membrane tension where membrane-cortex interactions 
are weakened. Using Flipper-TR, we show that the in-plane membrane tension is reduced at the rear 
of cells moving in 3D (Figure 1F). Optical trap-based tether pulling shows a very similar trend in cells 
on 2D rigidity gradients, where this approach measures the product of both in-plane membrane 
tension and membrane cytoskeleton connections. Interestingly, increasing membrane-cytoskeleton 
attachments using CA-ezrin has a significant effect on caveolae recruitment and rear retraction (Figure 
2D, E). This suggests that, in the context of caveolae formation, the in-plane membrane tension and 
membrane-cytoskeletal linkage could be linked. 
Whilst caveolae have been shown to localise to the cell rear in 2D24,28–31, their function there has been 
poorly understood. Our data demonstrate that caveolae act to recruit a RhoA GEF, Ect2, which 
activates RhoA to coordinate the retraction phase of migration. Polarisation of membrane tension 
(and caveolae) is less apparent on uniformly stiff substrates, but it is possible that caveolae play a 
similar regulatory role in some cell types during the retraction phase of the migration cycle on these 
surfaces. 
Caveolae are known to function as endocytic carriers24, but in our study the role of caveolae appears 
to be related to their capacity to form where the plasma membrane is under low tension. Indeed, 
acute temporal or spatial manipulation of membrane tension (using osmotic shock or rear-localised 
CA-ezrin) abrogates caveolae formation and rear retraction (Figure 3). sTEM demonstrate the 
accumulation of caveolae around the retracting rear membrane, including multilobed structures and 
caveolae with clear membrane-associated neck structures (Figure 2H). In support of this EHD2, which 
stabilises the neck of caveolae, is required for rear retraction and localises to caveolae at the cell rear 
(Figure 2G, S4G). However, in our sTEM images, many caveolae are present close to the retracting rear 
plasma membrane with no apparent neck (Figure 2H), and it is not clear whether this is a limitation of 
the z-sectioning approach, or if these represent internal caveolae structures. Given that some 
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caveolin-1 puncta appear to internalise after breaking the positive feedback loop that establishes 
rapid retraction (Figure 7), it remains possible that caveolae internalisation can occur from the cell 
rear and could act as an important step particularly when migrating cells change direction or arrest.  
Previous studies have implicated caveolae in substrate stretch-mediated activation of 
RhoGTPases54,55, although cell-matrix adhesion complexes play a major role in RhoA activation in 
response to such uniformly applied strain56. Caveolin-1 has been shown to promote RhoA activity by 
suppressing Src and the RhoA inactivator p190RhoGAP38, and is implicated in the generation of 
actomyosin contractility in cancer-associated fibroblasts, activating RhoA to promote reorganisation 
of stromal matrix57. In addition, it is now clear that caveolae play a role in protecting against 
mechanical strain in numerous cell systems by buffering against increasing membrane tension23–26.  
Our study extends these findings, suggesting that when cells generate directional traction force in a 
durotactic gradient, contractility within the actin cytoskeleton along the front-rear axis transmits a 
signal through decreased rear membrane tension that is sensed by caveolae to promote RhoA 
activation via Ect2, which could itself be directed to the membrane by interaction with lipids, as is the 
case prior to cytokinesis43,45. Downstream of RhoA, the effector kinases ROCK1 and PKN2 each play 
key roles in actin organisation and rear retraction (Figure 4, S4), and a specific requirement for PKN2 
in cell migration has previously been shown in cancer cells and in vivo58,59, suggesting that RhoA 
effector kinases synergise to control F-actin organisation and contractility in rear retraction. 
Surprisingly, the effects of caveolae disruption and RhoA signalling intervention are confined to a large 
region at the back of migrating cells, suggesting that this signal regulating F-actin is compartmentalised 
to the cell rear. The nucleus is limiting in migration through complex environments and can even 
rupture under force exerted on it60–63, and it is therefore possible that this large organelle acts to 
partition cytoskeletal regulation.  
Cell migration is a widely studied phenomenon in 2D, yet still relatively poorly characterised in more 
physiological 3D environments such as the interstitial matrix encountered by metastatic cancer cells 
and fibroblasts in wounding18. Here, we have identified a mechanism that controls the least well 
understood phase of the migration cycle, rear retraction. By establishing a positive feedback loop 
resulting in hyperactivation of RhoA, membrane tension could act as a mechanical signal that allows 
cells to move rapidly with high directional persistence into fibrotic areas (e.g. wounds) or promote 
cancer invasion. 
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Materials and methods 
Cell culture and transient transfection 
A2780 human ovarian cancer cells were maintained in RPMI-1640 medium (Sigma-Aldrich) 
supplemented with 10% (v/v) foetal calf serum, 1% (v/v) L-Glutamine and (v/v) 1% Antibiotic-
antimycotic (both Sigma-Aldrich); telomerase-immortalised fibroblasts (TIF) cells, mouse-embryonic 
fibroblasts (MEF) cells and H1299 human lung cancer cells (expressing control vector or mutant p53-
273H) were maintained in  Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich) containing L-
Glutamine and supplemented with 10% (v/v) foetal calf serum, and (v/v) 1% Antibiotic-antimycotic 
(Sigma Aldrich); and N15A64 Pseudomyxoma peritonei (PMP) cells were maintained in Dulbecco's 
modified Eagle's medium (DMEM) (Sigma Aldrich) supplemented with 10% FCS, 25 mM HEPES, 5 
μg/ml Insulin, 10 mM L-Glutamine and (v/v) 1% Antibiotic-antimycotic (Sigma Aldrich). All cell lines 
were incubated at 37 °C in a humidified 5% (v/v) CO2 atmosphere. All siRNAs and fluorescent 
constructs were transiently transfected by electroporation using a nucleofector (Amaxa, Lonza) using 
solution T, programme A-23, 3ug DNA / 5l 20 mM siRNA as per the manufacturer’s instructions. 
Experiments were performed ~24 h after nucleofection unless otherwise stated. 
Reagents 
ROCK/PKN inhibitor Y-27632 65 was used at 10 µM; ROCK inhibitor H-1152 was used at 2 µM; actin 
polymerisation inhibitor Cytochalasin-D (Sigma) was used at 2 µM; caged Cytochalasin-D was 
developed in the del Campo lab (manuscript in submission) and used at 50 µM as outlined below. 
siRNAs were as follows: Cav-1 – individual Hs_CAV1_9 FlexiTube 5’ AAGCATCAACTTGCAGAAAGA 
(Qiagen) and Hs_CAV1_10 FlexiTube 5’ AAGCAAGTGTACGACGCGCAC (Qiagen) (referred to as Cav-1 
siRNA-A and Cav-1 siRNA-B respectively here, all Cav-1 knockdown experiments were performed with 
each individual siRNA at separate times in comparison with separate control siRNAs); EHD2 – pooled 
FlexiTube GeneSolution (Qiagen); RhoA – 5’ ATGGAAAGCAGGTAGAGTT (Eurofins); ROCK1 – Silencer 
Select Pre-Designed (Life Technologies, 5’ -GCTTGTAGGTGATACACCTTT); ROCK2 – Silencer Select Pre-
Designed (Life Technologies, 5’-GAGATTACCTTACGGAAAATT); PKN1-3- SMARTpool siRNA 
(Dharmacon); PKN-2 – individual 5’ GGAGCGCTCTGATGGACA (Eurofins); Ect2 – individual Hs_Ect2_5 
FlexiTube 5’ TTGCCTAGAGATAGCAAGAAA and Hs_Ect2_7 FlexiTube 5’ GTCGCCCGTTGTATTGTACAA; 
Ect2, Vav2, PLEKHG5, DOCK1, ELMO2 – all pooled Flexitube GeneSolution (Qiagen); ARHGEF2 - 
SMARTpool: ON-TARGET plus ARHGEF2 siRNA. Sufficient knockdown was achieved with a single 
transfection after 24h for Cav-1-A; after 72h for ROCK1 and ROCK2; and double transfection after 
2x24h for Cav-1-B, RhoA, EHD2, Ect2-A, Ect2-B, Ect2 (pool), Vav2, PLEKHG5, DOCK1, ELMO2 and 
ARHGEF2. FRET biosensor Raichu-1237X 66 RhoA was kindly provided by Prof. M. Matsuda; mCherry-
Caveolin-1 construct 67 was kindly provided by Dr M. Bass; the GFP-AHPH Anillin construct 40 kindly 
provided by Prof. A. Yap; Emerald-Lifeact construct was kindly provided by Dr C. Ballestrem; 
farnesylGFP (GFP-membrane) construct was kindly provided by Prof. J Norman; GFP-Paxillin construct 
was kindly provided by Prof. M. Humphries; GFP-Ezrin wild type (WT) and GFP-Ezrin constitutively 
active (CA) were from 34. The following antibodies were used: Mouse anti-Fibronectin (Sigma-Aldrich); 
Rabbit anti-Caveolin-1 (BD Biosciences); Mouse anti-EHD2 (Santa Cruz Biotechnology, for western 
blot); Goat anti-EHD2 (Abcam, for IF); Rabbit anti-PTRF (Abcam); Rabbit anti-RhoA (Santa Cruz 
Biotechnology); Rabbit anti-ROCK1 and Rabbit anti-ROCK2 (both Cell Signalling); Mouse anti-Ect2 
(Santa Cruz Biotechnology, for IF); Rabbit anti-Ect2 (kind gift from Dr M. Petronczki, for western blot); 
Rabbit anti-Vav2 (Abcam); Rabbit anti-ARHGEF2 (GeneTex); Mouse anti-PLEKHG5 (Novus Biologicals); 
Rabbit anti-DOCK1 (ProteinTech); Goat anti-ELMO2 (Abcam); Mouse anti-Tubulin (DM1A), Mouse anti 
Akt-2 and Rabbit anti-Erk (Santa Cruz Biotechnology).  
SDS-PAGE and quantitative western blotting 
Cells were lysed in non-denaturing lysis buffer (200 mM NaCl, 75 mM Tris-HCl, pH 7.4, 15 mM NaF, 1.5 
mM Na3VO4, 7.5 mM EDTA, 7.5 mM EGTA, 1.5% (v/v) Triton X-100, 0.75% (v/v) NP-40, 50 μg/ml 
leupeptin, 50 μg/ml aprotinin, and 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride). Lysates were 
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clarified by centrifugation at 10,000 g for 10 min at 4°C. Cell lysates were resolved under denaturing 
conditions by SDS-PAGE (4–12% Bis-Tris gels; Invitrogen) and transferred to nitrocellulose membrane. 
Membranes were blocked with 1x Blocking Buffer (Sigma) and incubated overnight at 4°C with the 
appropriate primary antibody in 5% BSA and then at room temperature for 1 h with the appropriate 
fluorophore-conjugated secondary antibody in 1x Blocking Buffer. Membranes were scanned using an 
infrared imaging system (Odyssey; LI-COR Biosciences). siRNA efficiency was quantified in ImageJ 
following appropriate normalisation to a relevant loading control. 
CDM production 
Cell derived matrices were generated according to the method developed by the Yamada lab 68. 
Briefly, 6/12-well plastic (Corning) or 35 mm glass bottom (Mattek) plates were coated with 0.2% 
gelatin (v/v, Sigma Aldrich), crosslinked with 1% glutaraldehyde (v/v, Sigma Aldrich) and quenched 
with 1M glycine (Thermo Fisher) before TIFs were confluently seeded. DMEM medium supplemented 
with 0.25% ascorbic acid (v/v, Sigma Aldrich) was changed every 48h for 8 days. Cells were denuded 
with extraction buffer (20 mM ammonium hydroxide (NH4OH); 0.5% (v/v) Triton X-100) to leave only 
matrix; finally 1 nm DNAse was used for cleavage of phosphodiester linkages in the DNA backbone. 
Gradient CDMs with a stiffness differential were created by softening a region of the CDM using 
trypsin-coated magnetic beads, as trypsin has been shown to alter the stiffness of CDM 21. Specifically, 
10 µl magnetic trypsin beads (TakaRa) were pipetted onto a CDM and localised with a magnet, such 
that a small, crescent shaped region of the CDM grown on the circular glass bottom area of the dish 
(Mattek) was subjected to a high concentration of trypsin beads. CDMs were incubated with magnetic 
trypsin beads for 10 minutes at 37 °C in a humidified 5% (v/v) CO2 atmosphere, before being washed 
3x with PBS(+). Cells were plated onto non-uniform CDMs and imaged ~24 h after magnetic trypsin 
treatment, where the region of the interface of the softened, trypsin treated CDM (i.e. the area 
directly above the magnet during treatment) and the untreated CDM was carefully, manually 
identified and cells within this region subsequently analysed. 
Generation of polyacrylamide stiffness gradients (2D durotactic gradients) 
Polyacrylamide gels were made according to the Tse and Engler69 protocol with modification for 
gradient generation. Briefly, large area glass bottom plates (Nunc/Ibidi) or glass microscope slides 
(DeltaLab) were functionalised by coating with 0.1M NaOH then with 3-Aminopropyltriethoxysilane 
(APES, Sigma Aldrich), before being crosslinked with 0.5% glutaraldehyde (Sigma Aldrich) and dried; 
meanwhile manually cut 18 x 6 mm coverslips were rendered hydrophobic by coating with 
Dichlorodimethylsilane (DCDMS) for 4 minutes before also being dried. Statically compliant hydrogels 
were prepared by mixing appropriate concentrations of 40% (w/v) acrylamide, 2% (w/v) bis-
acrylamide stock solutions (both Sigma-Aldrich) and distilled water and rapidly polymerized by the 
enzymatic activity of 1/100 10% (w/v) ammonium persulfate (APS) and 1/1000 
Tetramethylethylenediamine (TEMED, both Sigma Aldrich). Acrylamide/bis-acrylamide 
concentrations for our two gels were: soft – 7.5% acrylamide, 1.5% bis-acrylamide, 91% H2O; and stiff 
- 25% acrylamide, 11.25% bis-acrylamide, 63.75% H2O. Gradients were formed by pipetting 2.7 or 5.4 
µl of two different stiffnesses of gel (depending on working distance requirements for subsequent 
microscopy) approx. 15 mm apart on the aforementioned functionalised glass before engaging the 6 
x 18 mm hydrophobic coverslips on the top surface of both gels. Natural diffusion and fluid flow of the 
two different gels into each other formed a confined 1-D gradient covering the 6 x 18 mm area at an 
approx. thickness of 50 or 100 µm.  Hydrophobic coverslips were removed in distilled water. Gels were 
then uniformly covered with the heterobifunctional protein cross-linker 0.2mg/ml sufosuccinimidyl-
6-(4-azido-2-nitrophenylamino)-hexanoate (sulfo-SANPAH; Thermo-fisher) which required activation 
by exposure with a 365-nm UV light source for 10 minutes. Finally, cells were coated with 10 µg/ml 
fibronectin in 50 nM Hepes buffer for 16 h before use. 
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Atomic force microscopy (3D-CDM) 
AFM experiments were conducted on a Nanowizard® 3 atomic force microscope (JPK Instruments AG), 
which was built onto an LSM 880 confocal microscope (Carl Zeiss AG). Colloidal probes for all 
experiments were prepared as follows. 10µm diameter polystyrene beads (Polysciences Inc.) were 
resuspended in ethanol before a drop was applied to a clean microscope slide. Epoxy resin was mixed, 
and a 20µl pipette tip used to apply a small amount of resin to the slide. A tip-less cantilever (Arrow™ 
TL2, NanoWorld) was then mounted onto the AFM, and the slide mounted onto the stage. Using the 
AFM, the cantilever was first lowered onto the epoxy resin, with any excess resin being removed by 
tapping the cantilever onto the glass surface. The cantilever was then lowered into contact with a 
single bead and raised, with a visual inspection via brightfield to confirm bead attachment and desired 
placement. Once attached, the resin was left to dry in air for a minimum of 20 minutes. Colloidal 
probes were used within 1 day of preparation.   
For front/rear stiffness measurements, the cells were kept at 37ºC within a PetriDishHeater™ (JPK 
Instruments AG) for the duration of the experiment. Cantilever calibration was conducted using the 
contact-free thermal noise method (at 37ºC within medium) prior to each experiment. Measurements 
of matrix stiffness were conducted with a threshold of 0.5nN and approach speed of 3µm/s. To obtain 
front and rear measurements the cantilever was manually positioned close to the pseudopod or cell 
rear, as determined by observation of direction of cell migration, and five repeat force/distance curves 
were obtained. To obtain stiffness gradient measurements a series of positions were probed; with an 
initial measurement at the border of a trypsinised area, followed by additional positions at ~600µm 
steps away from the area. At each position, an 8x8 grid of force/distance curves was collected within 
a 100µm2 area. 
All force/distance curves were analysed using the AtomicJ software70. Contact points were 
automatically calculated via the robust golden methodology, and curves fitted using the Sneddon 
model for spherical indenters assuming a Poisson ratio of 0.5. Mis-identified contact points were 
manually corrected if the contact point was visually obvious. Curves that could not be accurately fitted 
by the model were excluded from further analysis. For front/rear measurements, the Young’s Modulus 
for each curve was calculated and then each set of 5 were averaged to obtain a mean stiffness value. 
For gradient measurements, each set of 64 readings were averaged to obtain a mean stiffness value 
for the area at each position. 
Atomic Force Microscopy (2D gradients) 
Reduced Young’s Moduli of entire long-axis profiles of polyacrylamide gels were calculated using 
atomic force microscopy on a Bruker Catalyst mounted on a Nikon Eclipse Ti inverted light microscope, 
with a Bruker cantilever (OTESPA; 4-10nm tip radius). While the absolute long-axis of the gel 
containing the stiffness gradient was ~18 mm (see above), the total measurable distance by AFM was 
the middle 12-13 mm of the gel. Therefore the far left reachable point was taken as distance point 0, 
the far right point was taken as normalised distance 1 and other points (centre, three quarters etc) 
were measured and sampled relative to these extrema for all gels. End and centre points were first 
measured, and then further points were iteratively sampled based on neighbours to locate the 
position of the steep gradient in all gels. N = 25 to 100 readings were taken around a 2.5-5 µm sided 
square for each reading. Three gradients were analysed in this manner and showed clear consistency 
in absolute stiffness values and gradient location. AFM was performed on 100 µm thick gels. 
Membrane tension measurements by optical trap 
Membrane tension measurements were attained using the optical trap method. Tether  pulling  
experiments  were  realised  using  a  custom  made  optical  trap  (4W  1064nm  Laser  Quantum  
Ventus)  with  a  100x  oil  immersion  objective  (CFI  Plan  Fluor  DLL,  Nikon)  on  an  inverted  
microscope  (Nikon  Eclipse  TE2000-U)  equipped  with  a  motorised  stage  (PRIOR  Proscan).  The 
optical trap calibration was performed as described14.  Measurements  were  performed  by  attaching  
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concanavalin-A  coated  (50  μg/ml)  latex  beads  (1.9μm  diameter)  to  cells.  Bead position was 
recorded in bright field after tether formation.  Trap  force  was  then  calculated  using  a  custom  
made  ImageJ  script.  Trap  force  was  measured  twice  for  each  cell  (front  and  rear). All 
polyacrylamide gradients used for membrane tension measurements were 50 µm thick gels to fit 
within the working distance of the 100x objective. 
Live fluorescence imaging 
All fluorescent images were acquired using a CSU-X1 spinning disc confocal (Yokagowa) on a Zeiss 
Axio-Observer Z1 microscope with a 63x/1.40 Plan-Apochromat objective for CDMs or a 63x/1.15 LD 
C-Apochromat Korr water objective or 100x/1.30 Plan-Neofluar objective for polyacrylamide gradients 
(as stated) to allow for greater working distance. An Evolve EMCCD camera (Photometrics) and 
motorised XYZ stage (ASI) was used. The 445, 488, 515 and 561nm lasers were controlled using an 
AOTF through the laserstack (Intelligent Imaging Innovations (3I)) allowing both rapid ‘shuttering’ of 
the laser and attenuation of the laser power. Images were captured using SlideBook 6.0 software (3i). 
Randomly chosen representative polarised Lifeact-EGFP, Lifeact-Emerald, GFP-AHPH, GFPmembrane, 
Lifeact-RFP, mCherry-Caveolin-1, GFP-Cavin-1, GFP-Ezrin-WT, GFP-Ezrin-CA and GFP-paxillin 
expressing cells were captured with the appropriate excitation/emission spectrum and exposure time 
following ~ 4h spreading time on CDM and ~ 20h spreading time on gradient gels in Ham F12 medium 
or 1x Opti-Klear medium (Marker Gene Technologies Inc) supplemented with 10% (v/v) FCS (488 nm, 
50 ms exposure for GFP-Lifeact or Emerald Lifeact; 488 nm, 10 ms exposure for GFP-AHPH; 488 nm, 
100 ms exposure for GFP membrane, GFP-Ezrin-WT and GFP-Ezrin-CA; 561 nm, 50 ms exposure for 
RFP-Lifeact; 561 nm, 20 ms exposure for mCherry-Caveolin-1) every 15s – 1 minute for 5 - 10 minutes 
as indicated. Where appropriate, rear translocation was measured for all imaged cells in ImageJ across 
this 5 minute period by comparing the position of a part of the rear of the cell at the start of the 
timelapse with the exact same part of the rear at the end of the timelapse. For Colocalisation analysis 
of Cav-1 and Cavin-1, the Coloc2 tool in ImageJ was used to generate Pearson’s correlation coefficients 
in manually derived rear and perinuclear regions. Images are pseudocoloured using the red hot LUT 
(ImageJ) where appropriate to reveal differences in intensity. 
Forster Resonance Energy Transfer (FRET) imaging of RhoA activity was performed and quantified as 
described in detail previously 71. Concisely, randomly chosen polarised Raichu-RhoA expressing cells 
were captured every 15s for 5 minutes with 3 different excitation/emission spectra: CFP (445 nm) 
donor – CFP acceptor at 200 ms exposure; YFP (515 nm) donor – YFP acceptor at 50 ms exposure; and 
CFP donor – YFP acceptor at 200 ms exposure. Ratiometric FRET activity was then calculated by 
dividing the CFP-YFP channel by the CFP-CFP channel following automated image alignment. The YFP-
YFP channel was used to create a binary mask of the cell as it had the best signal to noise. Using this 
mask, a ring of the outermost 40 pixels of the cell was created and the front and rear quarters of the 
cell were isolated based on long-axis identification. The average of every ratiometric pixel value in a 
40 pixel wide, rearmost 25% area of the cell was then obtained and averaged over the 5 minute 
timelapse period to obtain the final single ‘average rear RhoA FRET ratio’ value per cell. 
Membrane tension measurements by FLIM microscopy 
For membrane tension measurements for cell in 3D CDM, the fluorescent probe Flipper-TR was used. 
Cells were spread on CDM for 4 hours in normal growth medium which was replaced with imaging 
medium (1x OptiKlear + 10% FCS) containing 1M Flipper TR, and incubated at 37˚C for 15 minutes to 
achieve appropriate labelling prior to imaging. Cells were imaged on a SP8 gSTED microscope using 
PicoQuant hardware/software for fluorescent lifetime imaging (FLIM) with 488 nm excitation and 575-
625 emission and a pixel dwell time of > 19.58 µs. Following imaging, a double exponential was fit to 
ensure a close fit (chi squared < 1.5) and the counts per pixel and lifetime per pixel images exported 
as 256x256 pixel single time-point, single Z-plane images. For quantification, membrane regions at the 
cell rear and cell front were manually identified using the count per pixel images, and the mean 
average lifetimes measured by assigning these front/rear ROIs to the lifetime per pixel images. For the 
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lifetime representative images, the lifetime per pixel image was smoothed by application of a Guassian 
blur with 1.0 pixel radius, multiplied by a mask created using the counts per pixel image to remove 
background/matrix lipid staining, and recoloured with a 16 colour LUT.   
Long term cell migration assay 
Cells were seeded at sparse (<25%, ~50,000 cells/well) confluency in typical growth medium on 6/12-
well CDMs and allowed to spread for ~ 6h. Images were acquired on an Eclipse Ti inverted microscope 
(Nikon) using a 20x/ 0.45 SPlan Fluar objective, the Nikon filter sets for Brightfield and a pE-300 LED 
(CoolLED) fluorescent light source with imaging software NIS Elements AR.46.00.0. Point visiting was 
used to allow multiple positions to be imaged within the same time-course and cells were maintained 
at 37°C and 5% CO2. The images were collected using a Retiga R6 (Q-Imaging) camera. 6 randomly 
chosen positions per cell were captured every 10 minutes over 16h. 5 randomly chosen cells per 
position (meaning 30 cells tracked per condition per experiment) were individually manually tracked 
using the ImageJ plugin MTrackJ every 3 frames (i.e. using 30 minute timepoint intervals). The 
Chemotaxis and Migration Tool was used to calculate the average speed and representative images 
of individual cells are shown where appropriate. 
Fixed cell high resolution imaging 
Cells were fixed in 4% paraformaldehyde (PFA) at room temperature following ~ 4h spreading on CDM 
or ~ 20h spreading on polyacrylamide gradients after non-confluent (~50,000 cells/plate) seeding. 
Membranes were permeabilised with 0.2% (v/v) Triton-X and blocked in 5% (w/v) heat-denatured 
bovine serum albumin (BSA) before being stained with appropriate antibodies as in reagents section. 
Cells were incubated with secondary antibodies Rabbit Alexa Fluor 647-conjugated, Rabbit Alexa Fluor 
594-conjugated, Rabbit Alexa Fluor 405-conjugated, Mouse Alexa Fluor 594 conjugated, Goat Alexa 
Fluor 594-conjugated (all Invitrogen), and/or Mouse Cy3-conjugated (Jackson ImmunoResearch) as 
appropriate. For detailed visualisation of actin structures, cells were stained with Phalloidin Alexa 
Fluor 488-conjugated (Invitrogen) or SIR-Actin (Spirochrome) as indicated, while Hoechst 33258 
(ThermoFisher) was used for nucleus staining. Plates were finally mounted in Prolong Gold or Diamond 
antifade reagent (Life technologies). All cell lines (A2780s, H1299s, MEFs and TIFs) were fixed and 
stained using the same protocol. 
Cells were imaged using a Leica TCS SP8 STED 3X microscope with an HC PL APO 100 x/1.40 oil 
objective using a HyD1 detector. A pinhole with 0.7 - 1 Airy units was used to further improve 
resolution while a notch filter was used for background reduction where possible. Images were 
captured using a white light laser (WLL) with excitation wavelengths 488, 550, 594 and 653 nm and 
appropriate emission spectra for green, cy3/red and far red respectively, while a Diode 405 laser was 
used with appropriate emission spectra for blue. For whole cells, Z-stacks were captured covering the 
entire Z-profile of the cell with captured at intervals of 0.3 µm at a zoom of 1x to 1.23x. Zoomed rear 
images were all captured separately at higher resolution (i.e. smaller pixel size) as Z-stacks covering 
the entire Z-profile with 0.2 µm z-step and a zoom of 4x. Images were deconvolved post capture using 
Huygens professional software with default settings. All subsequent analysis and quantification was 
performed on maximum intensity projections (MIPs) in ImageJ; all representative images shown 
throughout are MIPs (pseudocoloured using the red hot LUT where appropriate to reveal differences 
in intensity).  
3D spheroid invasion assay 
Spheroids of N15A/A2780 cells were grown using the hanging drop method. Cells were detached by 
chelation using PBS containing 3 mM EDTA and 0.6 mM DTT (N15As) or trypsin (A2780s), pelleted by 
centrifugation and resuspended at ~800,000 cells/ml in 1ml of 20% (v/v) Methocel (Sigma) and 80% 
(v/v) complete appropriate medium (see Cell culture section). 20 µl drops of cell suspension 
(containing ~16,000 cells each) were pipetted onto the underside of a standard 10cm tissue culture 
plate (Corning), inverted to form hanging drops and incubated for 24h at 37 °C in a humidified 5% (v/v) 
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CO2 atmosphere to allow formation of spheroids. 3-5 spheroids were extracted from the hanging 
drops by re-inversion and washing with complete medium using a Pasteur pipette, and resuspended 
in 100 µl collagen gel containing the following (all % denote v/v): 29.3% high molecular weight rat tail 
collagen (Corning); 0.7% 1M NaOH; 17.8% 10x PBS (Sigma); 3.6% 1mg/ml rat fibronectin (Sigma); 7.1% 
1mg/ml laminin (Sigma); and 41.5% neat medium (Sigma). This collagen gel/spheroid mixture was 
reverse pipetted into a well of an 8-well µ-slide (Ibidi) and allowed to polymerise for 10 minutes at 
room temperature and a further 30 minutes at 37 °C in a humidified 5% (v/v) CO2 atmosphere. 
Following polymerisation, complete medium supplemented with 30 ng/ml EGF and 25 ng/ml HGF was 
added to the well of the µ-slide, and incubated for 24h at 37 °C in a humidified 5% (v/v) CO2 
atmosphere to allow time for cells to invade, before fixation for 15 minutes at room temperature in 
4% PFA. Spheroids/cells were stained similarly as in the ‘Fixed cell high resolution imaging’ section 
above (doubling incubation times to allow for diffusion through the collagen gels). 
Fixed samples were imaged by Spinning disc microscopy with a 20x/0.8 Plan-Apochromat air objective 
for zoomed out, edge of spheroid images with a Z-stack covering 200 µm with slices every 10 µm, 
while higher resolution Z-stacks of individually invading cells were imaged on the same microscope 
with a 63x/1.15 LD C-Apochromat Korr water objective with slices every 1 µm. All analysis was 
performed on the higher resolution images, MIPs shown. 
Correlative Light and Electron Microscopy (serial TEM) 
For performing CLEM of polarized caveolae, we used 35 mm glass bottom dish (MatTek P35G-1.0-20-
C) for confocal imaging, allowing to select cells with polarized caveolin-1 (mCherry-Cav1). Low-
magnification images were acquired for mapping the position of the cell in relation to the 
micropatterns, that are visible using transmitted light. Once imaged, cells were first fixed in 
Glutaraldehyde 2.5% + paraformaldehyde 2% in PHEM buffer (0.1M) for 1h on ice. A secondary fixation 
of 0.05% Malachite Green + 2.5% Glutaraldehyde in cacodylate buffer (0.1M) was performed (for 25 
min on ice) before a post-fixation with 1%OsO4 + 0.8% KFe(CN)6 in cacodylate buffer (0.1M) (for 30 
min on ice). After 3x10 min water rinses, cells were stained with 1% uranyl acetate. The cells were 
dehydrated in sequential gradient alcohol baths and infiltrated with Epon (resin). Pipette tips were 
mounted over the cell of interest following overnight polymerization at 60°C. The following day, the 
tips were filled with Epon and polymerized again overnight at 60°C. For relocating the region of 
interest, the surface of the resin block was imaged using a stereomicroscope allowing accurate 
positioning of the cell of interest according to the micro-pattern.  Precise trimming was performed 
around the cell of interest. Finally, the resin block was serially sectioned (thickness : 100 nm) and all 
the sections were collected on electron microscope slot formvar grids (65 sections, distributed over 
13 grids). Sample sections were imaged on a transmitted electron microscope (Hitachi). Transmitted 
electron microscopy images were stitched, aligned and stacked with TrakEM272. 3D rendering of the 
electron microscopy acquisitions were performed with Amira aviso software. 
Correlative Light and SBFSEM 
Cells imaged on CDMs in gridded glass bottom plates were processed for SBFSEM using a high-density 
staining method involving reduced osmium, thiocarbohydrazide, osmium, uranyl acetate and lead 
aspartate73. The samples were dehydrated in staged ethanol (30, 50, 75, 90, 100, 100%) and then 
infiltrated with a mixture of Epon 812 (TAAB Laboratory Supplies Limited, UK) and ethanol (25% resin 
overnight, 50% resin for 8 hours, 75% resin overnight).  The next day the 75% resin was removed 
carefully with blue roll and rinsed twice with warm fresh 100% resin in order to remove the ethanol. 
The cells were left to infiltrate in 100% resin for 5 hours.  Cells were embedded in fresh resin by part 
curing a thin layer of resin for 4 hours, then applying a BEEM capsule with the tip removed (Agar 
Scientific, UK).  The BEEM capsule was filled with fresh resin to form an extension to allow easier 
manipulation.  The resin was cured at 60°C overnight.  The glass coverslip was separated from the 
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resin by freezing for a few hours then snapping off the embedded cells leaving the imprint of the 
etched glass on the surface of the resin. Using the imprint of the finder grid it was possible to localise 
the stained cells of interest.  These were crudely excised using a hacksaw and attached to 3view pins 
(EM Resolutions, UK).  Once attached to the pin they were trimmed more carefully for examination 
with a Gatan 3view74.  Note that the cell layer was never perpendicular to the cutting face, but this 
meant that it was possible to setup the microscope focus and imaging conditions after trimming the 
peak of the block.  The rest of the sample was left under the surface until the correct depth had been 
cut.  The block was coated in gold palladium in order to reduce charging in the microscope, thus in 
order to localise the cells of interest the pre-coated trimmed blocks were imaged using a dissecting 
microscope.  The dimensions of the block face and relative position of the cells could then be mapped 
and this information transferred onto the EM block face image. Serial block face runs were collected 
using a Gatan 3view (Gatan Inc) within an FEI Quanta 250 FEG (Thermo Fischer Scientific) scanning 
electron microscope at 3.8kV using 12nm pixels and 50nm cut thickness chamber pressure 0.4 Torr. 
Generation of rose plots for analysis of caveolae/actin/cell rear direction on gradient gels 
Angles of Cav-1 peak, leading edge protrusion and rear location in live experiments were manually 
calculated using the ImageJ angle tool by creating a segment from drawing a line parallel with the 
idealised direction of stiffness gradient (i.e. exactly right to left in all shown soft – left to stiff – right 
images) to the point of interest – Cav-1/Actin protrusion peak – and then a line from this point of 
interest to the centre of the nucleus: i.e. a point of interest exactly left of, right of, above or below the 
centre point would give angles 0, 180, 90 and -90o respectively. Rose plots were created in MatLab, 
angles were binned into twenty 18o segments; relative sizes of triangular segments are directly 
proportional to the number of cells with angles contained within each bin. 
Quantification of Cav-1/Cavin-1, Ect2 and Actin structures in fixed cells and membrane, Ezrin-WT 
and Ezrin-CA in live cells 
For quantification of localised Cavin-1 intensity, whole cell images were analysed with the interactive 
3-D surface plot v2.31 in ImageJ using a 128 grid size and smoothing factor of 3.0. Under these 
conditions, the peak intensities of the rear and non-rear or rear and nuclear cell regions were manually 
identified and the ratio rear peak / non-rear peak or rear peak / nuclear peak calculated, therefore 
providing inherent normalisation avoiding staining/expression discrepancies. For quantification of 
actin structures, a similar 3-D surface plot approach was used to manually identify the rear peak and 
leading edge peak of phalloidin 488 staining intensity to produce the normalised rear / leading edge 
ratio. For the quantification of localised GFP-membrane, GFP-Ezrin-WT and GFP-CA in live fluorescent 
cells, the interactive 3-D surface plot approach was similarly used on the first time-frame to measure 
the rear and front peaks of cells. These values were then normalised by dividing by the average of the 
rear and front peak intensities, such that when linked, pairwise front and rear values are plotted, all 
lines pass through the normalised peak intensity value 1.0. For Ect2, the normalised value for nuclear 
staining was additionally measured and normalised linked data of rear, nucleus and front shown. For 
line profiles of Cavin-1 intensity, the line profile tool was used in ImageJ: representative lines of length 
14.8021 µm were used from the rearmost point of the cell through towards the cell middle in zoomed 
images. Absolute Cavin-1 intensity was then quantified every 0.0507 µm (pixel width), smoothed by 
averaging with the neighbouring 5 pixel values and the average of all cells plotted with SEM. Cavin-1 
peak intensity position was determined by identifying the distance from the rearmost cell point of the 
single, non-smoothed pixel with the highest Cavin-1 value. 
Quantification of localised adhesion numbers 
A2780 cells transiently transfected with EGFP-Paxillin and mCherry-Caveolin-1 were imaged for 5 
minutes (1 minute per frame) with 9 Z-slices with a step size of 1 µm. Adhesions were manually 
identified by observing high intensity paxillin regions which persist  > 2 frames within individual Z-
slices, and all such adhesions were counted across all Z-slices (where it was assumed that the step-
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size was large enough to avoid duplicate countings). Adhesions behind the rearmost boundary of the 
nucleus were assigned as ‘behind’, while all other adhesions in advance of this boundary were counted 
as ‘in front’ relative to nucleus position. 
Reversible hypo-osmotic shock protocol and quantification of Cav-1 localisation and accumulation 
For live imaging experiments using the reversible hypo-osmotic shock, cells expressing Emerald lifeact 
+ mCherry-Caveolin-1 were imaged in isotonic control medium (1x Opti-Klear with 10% (v/v) FCS) as 
outlined in the section above for 10 minutes using point visiting, capturing at 1 minute intervals. The 
medium was then rapidly (~4 minutes) replaced using an aspirator and 1ml pipette with 50% 1x Opti-
Klear + 50% distilled water and all cells were subsequently imaged for 10 minutes in osmotic shock 
conditions. The osmotic medium was then rapidly (~4 minutes) replaced with isotonic 100% 1x Opti-
Klear using an aspirator and pipette and imaged for a further 20 minutes. As a result, the same cells 
were imaged and analysed in isotonic conditions pre-shock, osmotic shock conditions, and isotonic 
conditions post-shock. 
For quantification of Cav-1 intensity during the reversible hypo-osmotic shock assay, the intensity of 
mCherry-Caveolin-1 expression was measured in manually drawn regions at the rear and in the centre 
of imaged cells using ImageJ software. The same drawn ROIs were moved according to cell 
translocation so that the intensities were determined for the 11 timepoints pre-shock, the 11 
timepoints under shock conditions and the 11 timepoints post-shock. All measured intensities were 
background subtracted and normalised to the intensity at the first timepoint t = 0, such that 
normalised timecourse profiles for the rear and central regions of all cells for the full > 30 minutes of 
the assay were generated. Each timepoint was then averaged across all cells analysed and the average 
timecouse profiles for all rear and all central regions was plotted with SEM bars shown.  
For live analysis of Cav-1 accumulation at the rear of cells, osmotic shock was used to induce cells into 
a state with initially low rear Cav-1 (by incubation in osmotic medium for ~10 minutes) before the 
medium was replaced with isotonic medium via rapid aspirator pump and immediate pipetting. 
Throughout this process, laser-based (point visiting) Definite Focus was used via Slidebook software 
such that cells were captured 30-60s post media change without need for manual refocusing. Cells 
were imaged for a further >10 minutes using Definite Focus. For quantification, the segmentation tool 
used for FRET analysis (above) was adapted to create a binary mask using the mCherry-Cav-1 staining. 
The mean average intensity of the mCherry-Cav-1 intensity within the rear 10% and remaining 90% 
within the binary mask corresponding to the whole cell was then automatically measured for the pre 
and all post media change timepoints, and normalised upon division by the maximum value (such that 
all other values < 1). The average time-course lines for the normalised average Cav-1 intensity were 
plotted for the rear and rest of cell regions, with quadratic curves fitted in GraphPad Prism to indicate 
a smooth, quadratic accumulation of Cav-1 at the cell rear. 
Hypo-osmotic shock for fixed cells and FRET analysis 
Cells expressing Raichu-RhoA were imaged in control medium as outlined in the section above for 5 
minutes. The medium was then rapidly replaced with 50% Ham F12 + 50% distilled water and cells 
were subsequently imaged between 10 – 30 minutes post osmotic shock. Quantification of cell rear 
movement and FRET ratiometric activity were performed as before. For fixed cell imaging experiments 
using hypo-osmotic shock, cells were seeded on CDMs and left to spread for ~4h. The medium was 
then replaced with either normal growth medium for the control case or 50% medium + 50% distilled 
water for the hypo-osmotic shock and incubated for 10 minute before being fixed, stained and imaged 
as above.  
Live Y27632 and H1152 treatment 
For experiments using live Y27632 treatment, cells expressing mCherry-Caveolin-1 were captured in 
the control state across a period of 5 minutes, treated with Y27632 via direct addition to the medium, 
rapidly refocused within ~ 5 minutes and the same cells imaged for a further 1h, capturing every 30s. 
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Cells were also left for 1h without treatment to affirm that rear Cav-1 loss was not as an artefact of 
longer term imaging. For quantification, the rear / non-rear ratio of Cav-1 intensity was calculated 
using the 3-D surface plot in ImageJ (see Quantification of Cav-1/Cavin-1, Ect2 and Actin structures in 
fixed cells and membrane, Ezrin-WT and Ezrin-CA in live cells section above) for the first time point 
before Y27632 treatment and for a randomly chosen time point between 30 and 60 minutes post 
treatment, averaged across all captured cells and compared. 
For live H1152 treatment, cells expressing Emerald-Lifeact and either control or Cav-1 siRNA-A were 
imaged for 5 minutes, treated with H1152 via direct addition to the medium, then imaged for a further 
5 minutes. Throughout, Definite Focus was used to avoid any manual refocusing time, such that frames 
were taken every 30s before, (during) and after drug treatment. The forward translocation of the rear 
was manually measured for both transfection conditions without (before) and with (after) H1152 
treatment, where negative values correspond to backwards movement. 
Global and caged Cytochalasin-D treatment 
For global Cytochalasin-D treatment, cells expressing GFP-lifeact + mCherry-Caveolin-1 were treated 
with cytochalasin-D at 2 µM and imaged 10 minutes following treatment with typical capture 
conditions. Photo-activatable ‘caged’ Cytochalasin-D was produced in the del Campo lab (manuscript 
in submission) and used as follows: Cells expressing GFP-lifeact + mCherry-Caveolin-1 were first 
treated with 50 µM immediately prior to capture. A 5 x 5 µm ROI was drawn using Slidebook 6.0, 
positioned such that the ROI was completely outside the cell area (as determined by lifeact expression) 
but within ~ 10 µm the rear of the cell (and such that the rear was the closest part of the cell to the 
ROI). After 2 fluorescent frame captures using the 488 nm and 561 nm lasers (to ascertain the GFP-
lifeact and mCherry-Caveolin-1 expression pre photo-manipulation) the 405 nm emission photo-
manipulation laser was used to illuminate each pixel in the previously drawn ROI for 10ms each 
(meaning the whole region was photo-activated for a total of ~6.5s since there are 5.12 pixels per 
micron). Cells were then imaged for a further 10 minutes with normal fluorescent conditions (as it was 
deemed that with captures longer than 10 minutes the activated Cytochalasin-D may diffuse to other 
areas of the cell). For the control comparison, cells were subjected to exactly the same photo-
manipulation protocol in the absence of any drug treatment. 
For quantification, the average mCherry-Caveolin-1 intensity within a manually drawn region at the 
rear of the cell pre-photo-manipulation (called rear pre), a region at the rear of the cell 10 minutes 
post-photo-manipulation (rear post), a region at the centre of the cell pre-photo-manipulation (centre 
pre), and a region at the centre of the cell 10 minutes post-photo-manipulation (centre post) were all 
measured using ImageJ and background subtracted. The ratio ((rear pre)/(rear post))/(centre 
pre)/(centre post)) was then calculated and used as a single metric to describe rear Cav-1 loss upon 
caged Cytochalasin-D treatment, where the treated cells were compared to untreated (but photo-
manipulated) cells. 
Statistical analysis of experimental results 
Box and whisker plots show mean as ‘+’, whiskers generated using Tukey method. All statistics shown 
on box and whisker graphs with two conditions describe unpaired student T tests while for all box and 
whisker graphs with > two conditions a one-way ANOVA test for multiple comparisons has been used. 
For all linked line graphs concerning trap force data, pairwise Mann-Whitney tests were used to 
compare the front and rear membrane of the same cells directly, while data from all other linked line 
graphs have been subjected to paired T tests. All statistical analysis has been performed with 
GraphPad Prism software, where **** denotes p < 0.0001, *** denotes p < 0.001, ** denotes p < 0.01 
and * denotes p < 0.05. 
Model construction 
Our model of rear retraction incorporates 19 variables of which 12 are individual proteins (shown in 
green, yellow or cyan), 6 are empirical entities pertaining to stiffness, tension, polarisation, actin 
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alignment and retraction itself (in orange, pink or red) and the caveolae complex simplified to a single 
node. While all variables coloured orange, yellow, pink or red - and reactions there-between - are 
included based on findings/hypotheses confirmed or originated in this paper, variables coloured green 
or cyan are included to augment our study based on literature evidence. Green nodes link caveolae to 
RhoA activity while cyan nodes are intermediaries between ROCK1/PKN-2 activation and actin 
alignment/MLC phosphorylation. We included Src, the GTPase activating protein (GAP) p190RhoGAP 
and Ect2 as the RhoA guanidine nucleotide exchange factor (GEF) as ‘green nodes’ with 
activation/inhibition reactions as shown since: (i) Cav1 can interact with RhoA 75 but shows no 
structural evidence of being a GEF 76 so naturally must act via a GEF for GTP hydrolysis of the small 
GTPase; (ii) Cav1 can interact with the RhoA activator/GEF Ect2 and control the localisation and activity 
of a RhoA inactivator/GAP p190RhoGAP to regulate RhoA activity 77; and (iii) Src can phosphorylate 
Cav1 on Y14 to influence Cav1 expression and promote caveolae formation 77, or oligomerisation and 
release 78. Src also controls p190RhoGAP activity which directly inhibits RhoA 79, and pY14-Cav1 binds 
to and activates Csk, a ubiquitously expressed inhibitor of Src 79. DRF (Diaphanous-related formin), 
Limk, Cofilin, CPI-17 and MLCP (Myosin-light-chain phosphatase) and activation/inhibition reactions 
there-between were included as ‘cyan nodes’ based on the strong evidence that: (i) Formins are 
always required to some extent for efficient F-actin polymerisation and can be activated directly by 
RhoA or Rock1 80; (ii) ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the 
activation loop 81; (iii) Limk phosphorylates cofilin at Ser 3 both in vitro and in vivo which abolishes the 
ability of cofilin to bind and depolymerize actin 82; (iv) Cofilin universally disassembles actin filaments 
so acts as an inhibitor to rear actin alignment 83; (v) Phosphorylation of CPI-17 at Thr(38) by Pkn-2 or 
ROCK1 enhances the inhibitory potency of CPI-17 towards MLCP 84; and (vi) the primary function of 
MLCP is to oppose myosin phosphorylation whereby kinase and phosphatase activities are mutually 
antagonistic and in competition 85. 
ODEs formulation 
The ordinary differential equations (ODE) model was built with the following specifications: 
(i) All reactions use mass-action kinetics; this is the simplest kinetic scheme to use and in the 
absence of either more detailed numerical data or suggestions of other more relevant dynamics at 
play in vitro, is the most sensible starting point for a kinetic model. 
(ii) All variables, both proteins and biophysical entities, can be in an active, inactive or bound 
state with a conserved moiety; proteins can certainly be active, inactive or bound in cells. The 
biophysical entities are assigned an ‘active’ or ‘high’ state, and an ‘inactive’ or ‘low’ state to be 
consistent with the protein variables within the same model as convention, although the ‘inactive’ or 
‘low’ states can be regarded as dummy variables, while the ‘high’ states are the actual outputs of 
interest. For example the ‘high rear retraction’ corresponds to the instantaneous velocity of the rear, 
while the ‘high polarised substrate stiffness’ input corresponds to the steepness of theoretical 
gradient of the substrate. This also ensures all variables remain finite, see below. 
(iii) The value of all variables is normalised and confined between 0 and 100 units for all time; This 
ensures that the value of all variables in the model remain finite (i.e. that a cell cannot express an 
infinite amount of protein or that rear retraction cannot be infinitely fast which would be biologically 
implausible). This normalisation is such that protein and biophysical entity levels can be comparable 
and conceptualised on the same scale, while also conveniently overcomes the lack or real 
experimental expression level data. 
(iv) Reactions involving two proteins are two step processes whereby the proteins first bind 
together then the activation state of one/both proteins change/s as desired; evidence suggests for 
many protein-protein interactions that activation or inhibition requires binding of the proteins before 
a state change, for example The GEF Ect2 binds to GDP bound RhoA before promoting the switch to 
the GTP active form of RhoA. 
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(v) Reactions involving at least one biophysical entity are one step processes whereby the 
activation state of at least one variable involved in the reaction changes directly as desired; it makes 
no sense to conceptualise that polarised contractility binds to high membrane tension for example, 
therefore one step state changes are sufficient for the required kinetics. 
(vi) All reactions which only involve proteins or only involve biophysical variables are reversible 
where the backwards direction is at most 10% the rate of the forward direction, decreased tension 
activating caveolae and aligned Actin and p-MLC activating Acto-myosin contractility are non-
reversible; Reversibility of protein-protein interactions are well reported, keeping most reactions as 
reversible to a small extent prevents an implausible high resting state, while a biophysical entity 
relapsing to a protein or vice versa is conceptually impossible. 
(vii) All proteins and biophysical entities are subject to a turnover term, whereby there is a 
constant flux from the active state to the inactive state for all variables when not explicitly activated 
upstream. Without turnover and/or reversibility, variables such as rear retraction stay in an active, 
high level steady state despite lack of active upstream activators which is physiologically unrealistic: 
rear retraction requires Acto-myosin contractility and aligned Actin constantly and this formulation 
ensures this.  
Note since the potent inhibitor of p-MLC, MLCP is already included explicitly in the model, and these 
are almost like two forms of the same protein, the turnover of p-MLC is not included. To balance this 
and since p-MLC is not a protein but a specific state thereof, the activation of p-MLC is one-step rather 
than two step binding then activation. Implementing p-MLC with binding and turnover does not alter 
general findings of the model provided rates are balanced accordingly. 
Initial conditions 
For unperturbed simulations, the initial conditions (ICs) used are the input ‘polarised substrate 
stiffness’ set to the maximum 100, active Src set to 50, active Cofilin and MLCP set to 100, while the 
active form of all other is set to 0. The polarised substrate stiffness IC was taken as it is the nominated 
external input of the model, required to initiate the proceeding dynamics downstream. Cofilin and 
MLCP were set to 100 since these are inhibitory variables with no explicit activators, such that the only 
way these can be active is when they start active, while Src is set at 50% active initially since it has no 
upstream activator but has both an activator and inhibitory role on downstream effectors. 
Parameter values 
All parameter values were based on order of magnitude predictions, i.e. were subject to the constraint 
that all values were 1 ×  10−𝑛 for an integer n greater or equal to 1. The order of magnitude approach 
was adopted since the appropriate kinetic data was unavailable, and more specific rates would not be 
justifiable and may promote an over-determined model. All rates were checked with half and double 
values, and the general topology and behaviour was unchanged. Parameters were initially set based 
on literature findings and certain assumptions and then iteratively, improved based on biological 
plausibility of simulated outputs. In particular, it was assumed that protein-protein interactions occur 
with higher rates than those involving biophysical entities because: (i) protein-protein interactions are 
two step (binding then state change) so are already going to be slower overall, and (ii) it is known that 
protein-protein interactions such as binding can be incredibly quick in vitro, while the precise kinetics 
of polarised contractility leading to decreased tension for example are likely to be slower as these 
events are more complex at the molecular level. All parameter rates used can be seen in the full list 
of ODEs used in the model below. 
Model simulation and perturbation 
The model was built and simulated using Copasi software version 4.15 86. Deterministic simulations 
were performed using the LSODA method for the first 10000 seconds with an interval size of 25s. The 
time-course outputs for all variables in the model were checked for plausibility, however the outputs 
43 
 
for a chosen subset of variables are shown for simplicity. For a priori knockdown simulations, all 
variables were kept the same as the unperturbed simulation apart from the initial amount of the 
relevant variable (RhoA, and Cav-1), which were both reduced to 12% of total concentration. For 
substrate transition simulations, ‘polarised substrate stiffness’ was assigned to change from 100 to 0 
or 0 to 100 at t = 4000s. For simulation of the osmotic shock assay, the rate of transition from 
decreased membrane tension to increase membrane tension was increased 1000-fold (from 0.01 to 
10) at time t = 4000s, and then returned to the original value (0.01) at t = 7000s to mimic return to 
isotonic conditions. For mimicry of Y-27632 treatment, an event at t = 5000s was added to the 
simulation where the turnover rate for Rock1 and Pkn-2 was increased 1000-fold (from 0.01 to 10); 
for ‘global’ cytochalasin-D treatment, the turnover rate of F-actin (i.e. the rate at which F-actin 
transitions to G-actin) was increased 100-fold (from 0.01 to 1) while for ‘caged’ cytocholasin-D 
treatment the turnover rate of F-actin was increase 20-fold (from 0.01 to 0.2), both events occurring 
at t = 5000s. 
Parameter sensitivity analysis 
Parameter sensitivity analysis was performed using the built-in Copasi tool with Retraction/Recoil as 
the target and all rates in the model as the analysed objects. Scaled parameter analysis was run, such 
that the concurrent rates used in the model were factored in to the apparent importance of each 
parameter, while the total of the scaled parameter sensitivity sums to zero. 
ODE equations 
The full list of ODE equations used in the model, including all rate values, are included in the following 
pages (where GEF denotes Ect2). 
Code will be made available upon acceptance in the Biomodels database 
(https://www.ebi.ac.uk/biomodels-main/). 
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Figure Legends 
Figure 1: Cell rear dynamics in matrix directed cells. 
 (A) Left: A2780 ovarian cancer cells expressing mEmerald-Lifeact were seeded in 3D cell-derived 
matrix (CDM) for 4 hours before spinning disk confocal microscopy. Single z-slice stills from movies 
are shown 300s apart. Dashed yellow line indicates the position of the rearmost part of the cell in the 
first frame; Top right: Matrix Stiffness measurements immediately in front of and behind cells 
migrating in CDM assessed by AFM (10µm polystyrene bead mounted to the cantilever; each cell’s 
measurement joined by a black line, N=20 cells analysed across 3 repeats); Bottom right: Orientation 
of migration in untreated matrix shown by rose plot (N>35 cells across 3 repeats). (B) Left: 3D CDM 
were locally softened using trypsin-coated magnetic beads to generate gradient CDMs, and A2780 
cells expressing mEmerald-Lifeact seeded and imaged as in (A; cells between ~500 and 1500m from 
the softened area were imaged); Top right: Average stiffness measurements in CDM relative to 
softened area area assessed by AFM before seeding of cells (3 separate CDMs analysed with 25-100 
readings per area; Bottom right: Orientation of migration with respect to area of locally softened 
matrix (at 360°) shown by rose plot (N>35 cells across 3 repeats). (C) Left: A2780 cells expressing 
mEmerald-Lifeact were seeded onto 2D FN-coated durotactic gradients for 16 hours and imaged as in 
(A); Top right: AFM measurement of stiffness of 2D durotactic gradients (4-10nm tip; N=3); Bottom 
right: Orientation of migration with respect to the gradient shown by rose plot (N=58 cells across 3 
repeats). (D) Representative images from optical trap membrane tether based analysis of membrane 
tension. Rear and front images of the same cells taken in different fields of view; white dotted line 
indicates separation of images. (E) Left: Paired trap force measurements at the front and rear of cells 
on durotactic gradients (N=29 cells across 3 repeats); Right: Paired trap force measurements at the 
front and rear of polarised cells migrating on uniform stiff gradients (N=10 cells across 3 repeats). (F) 
Left, centre: Representative cells migrating in CDM stained with Flipper-TR membrane tension probe 
~30 minutes prior to FLIM imaging where (Left) shows photon counts per pixel and (Centre) shows 
FLIM lifetime per pixel with a 16-colour look up table (LUT) applied as shown; Right: Pairwise average 
Flipper-TR lifetime in manually identified membrane regions at the front and rear of cells (N=9 cells 
across 3 repeats, note lower lifetime corresponds to lower membrane tension). Yellow arrows indicate 
direction of movement. *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, not significant. 
Figure 2: Low membrane tension promotes caveolae formation at the rear of fast moving cells in 3D 
and durotactic gradients.  
(A) Left: A2780 cells expressing EGFP-cavin-1 and mCherry-caveolin-1 were seeded and imaged as in 
Fig. 1(A) Right: Pairwise Pearson’s correlation coefficient for co-localisation of EGFP-cavin-1 and 
mCherry-caveolin-1 in rear compared to peri-nuclear regions (mean values shown above, N=28 cells 
across 2 repeats analysed). (B) A2780 cells expressing Lifeact-EGFP and mCherry-caveolin-1 were 
seeded and imaged as in Fig. 1(A), maximum intensity projection (MIP) shown for whole cell (left), 
individual Z-slices for rear regions panel (right). (C) Left: A2780 cells expressing mCherry-caveolin-1 
were seeded onto 2D durotactic gradients and imaged as in Figure 1C (yellow line indicates outline of 
the cell); Right: orientation of caveolae with respect to the gradient shown by rose plot (N=58 cells 
across 3 repeats). (D, E) A2780 (D) or N15A (E) cell spheroids within collagen and fibronectin hydrogels 
were incubated for 24h to allow individual cells invade the local ECM. Left: Cells stained for F-actin 
(phalloidin) and Cavin-1 showing the spheroid (edge denoted by yellow dotted line) and an individual 
invading cells (yellow dotted box); Inset: Higher resolution image of the highlighted individual invading 
cells; MIPs of Z-stacks shown captured by long distance spinning disc confocal microscopy. (F) Pairwise 
quantification of normalised rear and nuclear Cavin-1 intensity in individual invading A2780 and N15 
cells away from spheroids, N>8 cells analysed form 3 different spheroids. (G)  A2780 cell seeded in 3D 
CDM and fixed and stained for F-actin, cavin-1 and EHD2; whole cell and separately captured zoomed 
rear MIPs of confocal stacks shown. (H) Fluorescence image of A2780 cells expressing mCherry-
Caveolin-1 allows targeting of single cells. Serial Transmitted electron microscopy (sTEM, 100 nm) of 
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the exact same cell is displayed (middle panels). Manual segmentation of the nucleus, the plasma 
membrane and caveolae is performed and displayed as a 3D model over the entire cell. Both caveolae 
connected to the plasma membrane (yellow) and caveolae-associated vesicles (pink) were segmented 
(segm. + sTEM image). Both structures were merged in yellow in the overall model. An individual sTEM 
image is presented. Insets show higher resolution images of multilobed (arrows) or membrane-
attached (arrowhead) caveolae (different z-section of the same cells). Scale bar 500nm (inset: 100nm). 
***, p < 0.001; ****, p < 0.0001. 
Figure 3: Increasing membrane tension abrogates rear caveolae formation and forward 
translocation.  
(A) A2780 cells expressing Lifeact-EGFP and mCherry-caveolin-1 were seeded into 3D CDM and imaged 
by spinning disk confocal microscopy before and during hypo-osmotic shock (0.5Xmedia), and after 
recovery in isotonic media. (B) Quantification of rear mCherry-caveolin-1 intensity before and during 
osmotic shock, and after recovery in isotonic medium. N=12 cells analysed across 3 repeats, SEM bars 
shown. (C) Top left: A2780 cells expressing mCherry-caveolin-1 were seeded as in (A) and imaged in 
osmotic shock (0.5Xmedia) and recovery isotonic media every 30-60 seconds immediately post- media 
change using Definite Focus; Top right: quantification of average normalised mCherry-caveolin-1 
intensity in 10% rear mask (white inset in images) and rest of cell regions over time following osmotic 
to isotonic switch (N=17 cells across 3 repeats, error bars show SEM, fitted quadratic curves showed 
in red and blue); Bottom: Montage of zoomed, 90˚ rotated rear region (highlighted by yellow box) 
immediately prior to and every 30s post- osmotic-isotonic switch showing mCherry-caveolin-1 
accumulation. (D) Left: A2780 cells seeded for 4 hours in 3D CDM expressing GFP-membrane (left), 
Ezrin wild type (WT, centre) or Ezrin constitutively active (CA, right) and imaged for a 5 minute 
timelapse to assess rear retraction; Centre: Pairwise quantification of normalised peak Ezrin WT (left) 
and CA (right) intensity within front and rear regions (N>32 cells per condition across 3 repeats); Right: 
Quantification of average rear forward movement during 5 minute timelapse of cells expressing GFP 
membrane, Ezrin WT and CA (N >39 cells per condition across 3 repeats). (E) Left: A2780 cells 
expressing GFP membrane, Ezrin WT or CA seeded in 3D CDM for 4 hours, fixed with PFA and stained 
for endogenous F-actin (phalloidin) and cavin-1, MITs of Z-stacks shown for merged (top) and cavin-1 
(bottom) channels; Centre: Quantification of rear/nuclear peak caveolin-1 staining intensity ratio for 
cells expressing GFP membrane, Ezrin WT and CA (N>11 cells per condition across 3 repeats); Right: 
Paired trap force measurements at the front and rear of cells expressing CFP Ezrin-CA on durotactic 
gradients (N=10 cells across 3 repeats). **, p < 0.01; ****, p < 0.0001; ns, not significant. 
Figure 4: Caveolae activate RhoA at the cell rear to control contractility and F-actin architecture. 
 (A) Left: Lifeact-mRFP expressing, control/caveolin-1 knockdown A2780 cells were plated in 3D CDM 
and retraction of the cell rear over 5 minutes measured by spinning disk confocal microscopy; Right: 
forward movement of cells over a 5 minute timelapse (N>74 cells per condition across 3 repeats). (B) 
Active RhoA location biosensor GFP-AHPH expressing A2780 cells were seeded in 3D CDM, fixed after 
6 hours and stained for endogenous caveolin-1, Z-stacks were captured by confocal microscopy (MIP 
shown). (C) Cell treated as in (B) imaged at high resolution, Pearson correlation 0.52; Spearman’s rank 
0.65. (D) Left: Ratiometric FRET imaging of control or caveolin-1 knockdown A2780 cells expressing 
Raichu-RhoA migrating in 3D CDM. Right: Quantification of ratiometric FRET in caveolin-1 knockdown 
cells (N>36 cells per condition across 3 repeats). (E) Quantification of ratiometric FRET of Raichu-RhoA 
expressing control and osmotic shock (0.5xmedia) treated cells in 3D CDM (N>27 cells per condition 
across 3 repeats). (F) Left:  Control or caveolin-1 knockdown  A2780 cells were seeded into 3D CDM 
and fixed after 4 hours, F-actin was visualized using SiR-actin and confocal imaging (MIPs are shown); 
Right: Ratio of F-actin intensity of the rear / front of cell (N>17 cells per condition across 3 repeats).  
(G) Control or RhoA knockdown A2780 cells were seeded into 3D CDM and fixed after 4 hours, F-actin 
was visualized using SiR-actin and confocal imaging (MIPs are shown). (H) Control, ROCK1 or ROCK2 
knockdown cells were seeded into 3D CDM and fixed after 4 hours; F-actin was visualized using SiR-
actin and confocal imaging, high resolution MIPs of rear cell regions shown. (I) Quantification of rear 
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/ front peak F-actin staining intensity of control and RhoA knockdown cells (N=10 cells per condition 
across 3 repeats). (J) Quantification of rear / front peak F-actin staining intensity of control, ROCK1 
and ROCK2 knockdown cells (N>17 cells per condition across 3 repeats). (K) Left: Control (left) and 
caveolin-1 knockdown (right) Emerald-Lifeact expressing A2780 cells seeded in 3D CDM for 4 hours 
and imaged by spinning disc confocal microscopy for 5 minutes prior to- (top) and 5 minutes post- 
(bottom) treatment with 1 µM H1152; Right: Quantification of rear movement of control and caveolin-
1 knockdown cells during 5 minute timelapses pre- and post- H1152 treatment (N=21 cells per 
condition across 3 repeats, note positive values correspond to forward movement and negative values 
to backwards movement of the rear). ***, p < 0.001; ****, p < 0.0001. 
Figure 5: Ect2 is recruited by caveolae to activate RhoA  
(A) Left, centre: Control (left) and Ect2 knockdown (centre) A2780 cells expressing membrane-
targeted Raichu-RhoA were seeded in 3D CDM for 4 hours and imaged by spinning-disc microscopy 
for 5 minutes timecourses to assess forward rear membrane translocation; Right: Quantification of 
average forward rear movement during 5 minute timecourse of control, Ect2, Vav-2 and PLEKHG5 
knockdown cells (N>46 cells per condition across 3 repeats). (B) Left: Ratiometric FRET imaging of 
control, Ect2, Vav-2 and PLEKHG5 knockdown cells treated as in (A); Right: Quantification of average 
rear region ratiometric FRET in control, Ect2, Vav-2 and PLEKHG5 knockdown cells (N>32 cells per 
condition across 3 repeats). (C) Left: Untransfected cells were seeded in 3D-CDM for 4 hours, fixed 
with PFA and stained for endogenous nuclei (Hoescht), F-Actin (phalloidin), Ect2 and Cavin-1, MIPs of 
whole cell and separately captured zoomed rear region shown for the merged, cavin-1 and Ect2 
channels right: Quantification of peak Ect2 staining intensity in rear, nuclear and front regions of the 
same cell (linked by black dashed line, N=17 cells across 3 repeats). (D) Left: Control (left) and 
individual caveolin-1-A knockdown cells (right) were seeded in 3D CDM for 4 hours, fixed with PFA and 
stained for endogenous F-actin (phalloidin) and Ect2, MIPs of Z-stacks shown for merged (top) and 
Ect2 (bottom) channels; Right: quantification of rear peak / leading edge peak Ect2 intensity levels of 
control and caveolin-1 knockdown cells (N>20 cells per condition across 3 repeats). ***, p < 0.001; 
****, p < 0.0001; ns, not significant. 
Figure 6: Mathematical modelling implicates a positive feedback based mechanism of rear 
retraction.   
(A) Schematic summary of key rear retraction events for migrating cells in 3D or durotaxis. (B) Wiring 
diagram of mechanical and protein-protein signalling interactions which leads to coordinated 
retraction, upon which the ODE model and simulations are based. (C) Simulations output of rear recoil 
speed (% activity) against time with polarized substrate stiffness remaining at 100% (red) or at 0% 
throughout the time course (yellow), or transitioning from 100% to 0% (gradient to uniform, blue, 
hidden by red line) or 0% to 100% (uniform to gradient, green) at time t = 4000s. (D) Simulation outputs 
for rear recoil speed and F-actin alignment (% activity) for unperturbed, RhoA and caveolae 
knockdown initial conditions. (E) In silico simulation of the reversible osmotic shock assay, where 
membrane tension is increased at t = 4000s and returned to basal level at t = 7000s; rear recoil speed 
and caveolae formation shown. (F) Predictive simulation of Y-27632 treatment effect on caveolae 
dynamics/rear recoil speed, where at t = 5000s ROCK1/PKN-2 inactivation rates are greatly increased. 
(G) Predictive simulation of ‘global’ cytochalasin-D treatment on caveolae dynamics/rear recoil speed, 
where at t = 5000s F-actin turnover rate is greatly increased. (H) As in G but for ‘local’ cytochalasin-D, 
where at t = 5000s F-actin turnover rate is moderately increased. 
Figure 7: F-actin stability and contractility maintain caveolar rear localization in migrating cells.  
(A) mCherry-caveolin-1 expressing A2780 cells were seeded onto 3D CDM and imaged after 4 hours 
by spinning disk confocal microscopy before (left panels) and after treatment with 10 µM Y27632. (B) 
Quantification of rear caveolin-1 intensity of cells as in (A) (N=23 cells across 3 repeats). (C) Control or 
ROCK1 knockdown cells were seeded into 3D CDM and fixed after 4 hours and stained for endogenous 
cavin-1 and F-actin (phalloidin), MIPs of confocal z-stacks are shown. (D) Line profile based 
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quantification of cavin-1 intensity across the rear portion of cells as in (C) (N>20 cells per condition 
across 3 repeats). (E) Distance in µm of peak cavin-1 intensity from the rear of cells as in (C) (N>20 
cells per condition across 3 repeats). (F) Control or individual Ect2 knockdown cells were seeded into 
3D CDM, fixed after 4 hours and stained for nuclei (Hoescht), F-Actin (phalloidin) and cavin-1, MIPs of 
confocal z-stacks are shown. (G) Left,: Cells were seeded in 3D CDM and stained with Flipper-TR > 15 
minutes prior to imaging as in Fig. 1F, same cell shown pre- (left) and ~30 minutes post- (right) Y27632 
treatment where (top) shows photon counts per pixel, (bottom) shows FLIM lifetime per pixel with a 
16-colour look up table (LUT) applied as shown; Right: Unpaired (top) and pairwise (bottom) average 
Rear – Front Flipper-TR lifetime difference in manually identified membrane regions pre- and post- 
Y27632 treatment (N>9 cells pre condition across 3 repeats). (H) A2780 cells expressing Lifeact-GFP 
and mCherry-caveolin-1 were seeded onto 3D CDM and imaged after 4 hours in the presence of caged-
CytoD (50 µM) before and after uncaging of a specific region behind the cell rear (indicated by yellow 
box). Right: Quantification of rear caveolin-1 intensity in cells before and 10 minutes after uncaging 
(N>30 cells per condition across 3 repeats). **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. 
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Supplementary information 
Figure S1-S7 
Movie S1-7 
Supplementary Figure Legends 
Figure S1: 3D migration in fibrillar matrix.  
(A) A2780 cells seeded within 3D CDM. Representative single plane images above, through and below the 
cell (top) and an xz projection s (bottom), where each dashed line denotes the relative positions of the single 
plane images. Cells/matrix were fixed and stained for fibronectin and F-actin (SiR-actin) prior to imaging with 
a Z step size of 0.27 µm. (B) A2780 cells moving in an unperturbed CDM (left) or a locally softened CDM 
(right), representative maximum intensity projections (MIPs) shown. Cells were fixed and imaged as in A. (C) 
H1299 cells were seeded onto FN-coated 2D durotactic gradients for 16 hours and imaged, orientation of 
migration with respect to the gradient is shown by rose plot. (D) Left: A2780 cells expressing farnesyl-EGFP 
(GFPmembrane) were seeded onto 3D CDM and imaged as in Fig. 1A. Right: Pairwise quantification of 
normalised GFP-membrane peak intensity at the front and rear of A2780 cells (N=33 cells across 3 repeats). 
(E) A2780 expressing Lifeact-GFP stained with lipophilic dye (Dil) moving in 3D CDM. Timelapse of the cell 
rear captured using Zeiss Airyscan. (F) Trap force at the front and rear of unpaired cells on durotactic 
gradients, untreated glass and uniform stiff gels and single membrane measurements of unpolarised cells on 
uniform soft gels; N>31 cells per condition analysed across 3 repeats for gradient; N>18 per condition across 
3 repeats for glass, N>12 cells per condition across 3 repeats for uniform stiff, N=6 cells across 2 repeats for 
uniform soft. (G) A2780 cells expressing EGFP-paxillin and mCherry-caveolin-1 were seeded in CDM for 4 
hours then imaged for 5 minutes, 9 Z-planes imaged every 1µm by spinning-disc confocal microscopy, 
representative MIPs of merged (left) and paxillin (right) channels shown; Right: Pairwise quantification of 
number of adhesions in front/nucleus region compared to behind nucleus region, N=31 cells across 3 repeats. 
****, p<0.0001. 
Figure S2: Caveolae localization in cells in 3D matrix and durotactic gradients.  
(A) H1299 cells expressing Lifeact-mEmerald and mCherry-caveolin-1 were seeded in 3D CDM and imaged as 
in Fig. 2(B). (B) H1299 non-small cell lung cancer cells were seeded in 3D CDM and fixed and stained for F-
actin and cavin-1. MIPs of confocal stacks are shown. (C) A2780 cells seeded on a CDM locally softened via 
trypsin beads, fixed as in B and stained for F-actin (SiR-actin) and cavin-1. Representative MIP shown. (D) 
A2780 cells in 3D CDM were fixed and stained for endogenous caveolin-1. Representative MIP of confocal 
stacks are shown. (E) H1299 cells expressing Lifeact-mEmerald and mCherry-caveolin-1 were seeded on 2D 
durotactic gradients and imaged as in Fig. 2(C). (F) A2780 cells on 2D soft, stiff, or durotactic gradients of 
stiffness (all coated with fibronectin) stained for F-actin (phalloidin) and cavin-1. Representative MIP shown. 
(G) A2780 cells on 2D soft, stiff, or durotactic gradients of stiffness (all coated with fibronectin) stained for F-
actin (SiR-actin) and caveolin-1. Representative MIP shown. (H) Orientation of caveolin-1 in cells as in (F) with 
respect to the stiffness gradient (N=30 cells across 3 repeats). (I) Average speed of A2780, H1299, 
Telomerase-immortalized fibroblasts (TIFs) or mouse embryonic fibroblasts (MEFs) cells in 3D CDM during 16 
hours timelapse. (J) Average intensity of mCherry-caveolin-1 at the rear of A2780, H1299, MEF and TIF cells 
moving in 3D CDM. (K) TIFs or MEFs were seeded in 3D CDM and fixed stained and imaged as in (B), 
representative images of poorly polarized highly spread morphology of TIFs and MEFs in 3D CDM. (L) Trap 
force measurements at the front and rear of elongated TIF cells, N=10 cells across 3 repeats. (M) TIFs and 
MEFs as in (K), displaying the polarised, shorter phenotype. (N) Morphology of TIFs and MEFs when 
undergoing rapid migration in 3D CDM. (O) Proportion of TIFs and MEFs that show elongated (typical) 
morphology versus shortened (rapid) morphology, and proportion of cells that exhibit high versus 
low/unpolarized cavin-1 at the cell rear. (P) A2780 cells expressing mEmerald-Lifeact and mCherry-caveolin-
1 were imaged migrating in 3D CDM, and fixed and processed for Serial Block Face SEM (SBFSEM).  The 
relative ease of data collection using SBFSEM meant that it was possible to generate correlative EM data 
from 9 different motile cells with sufficient resolution to allow identification of caveolae.  A volume render 
of the EM data is compared with the light microscope image to show that the cell morphology has not been 
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affected by fixation.  The enlargements show evidence of caveolae/multilobed caveolae (yellow arrowheads) 
at the rear of the cell, but no evidence of caveolae was seen in the peri-nuclear region. ****, p<0.0001. 
Figure S3: Increasing membrane tension supresses rear caveolae assembly in durotactic gradients and 
CDM.  
(A) A2780 cells expressing Lifeact-EGFP and mCherry-caveolin-1 were seeded onto 2D durotactic gradients 
and imaged before and during osmotic shock treatment (0.5Xmedia). (B) A2780 cells were seeded onto CDM 
and treated with osmotic shock (0.5Xmedia) or isotonic media, before fixation, staining and imaging of 
endogenous caveolin-1. MIPs are shown. Yellow line indicates outline of the cell. Insets MIPs of the cell rear 
captured using high resolution imaging. (C) Distance of rear retraction of A2780 cells in isotonic versus hypo-
osmotic shock in a 5 minute timelapse. N>61 cells per condition across 3 repeats. ****, p<0.0001. 
Figure S4 Caveolae control rear retraction through RhoA-ROCK1/PKN2 actin organisation  
(A) Caveolin-1 knockdown A2780 cells were plated in 3D CDM and speed of migration measured by timelapse 
microscopy over 16 hours. N=90 cells per condition across 3 repeats. (B) Representative images of control 
and caveolin-1 knockdown A2780 cells moving through 3D CDM. (C) Quantification of control and caveolin-
1 knockdown cell length whilst migrating in 3D CDM. N=90 cells analysed per condition across 3 repeats. (D) 
Efficiency of knockdown of caveolin-1 in A2780 cells. (E) Efficiency of knockdown of caveolin-1 in H1299 cells. 
(F) Left: Lifeact-mRFP expressing, caveolin-1 knockdown H1299 cells were plated in 3D CDM, imaged by 
spinning disk confocal microscopy and retraction of the cell rear over 5 minutes measured. Right: Forward 
movement of H1299s cells over a 5 minute timelapse. N>74 cells per condition across 3 repeats. (G) Left: 
Control and EHD2 knockdown A2780 cells expressing Lifeact-EGFP and mCherry-caveolin-1 migrating in 3D 
CDM imaged by spinning disk confocal microscopy. Centre: Average migration speed of control and EHD2 
knockdown cells migrating in 3D CDM for 16 hours. N=90 cells analysed per condition across 3 repeats. Top 
right: Distance of rear retraction of control and EHD2 knockdown A2780 cells in 3D CDM during a 5 minute 
timelapse N>80 cells per condition across 3 repeats. Bottom right: EHD2 knockdown efficiency in A2780 cells. 
(H) Left: Representative images of control and EHD2 knockdown A2780cells with coloured bars indicating cell 
length. Right: Quantification of control and EHD2 knockdown cell length whilst migrating in 3D CDM. N=90 
cells analysed per condition across 3 repeats. (I) Active RhoA location biosensor GFP-AHPH expressing A2780 
cells were seeded in 3D CDM and fixed after 6 hours. F-actin was visualized with SiR-actin, and cells imaged 
at high resolution. MIPs are shown. (J) Active RhoA location biosensor GFP-AHPH expressing A2780 cells were 
seeded on 2D durotactic gradients for 16 hours and imaged by spinning disk microscopy using a long working 
distance 63x objective. (K) Active RhoA location biosensor GFP-AHPH and mCherry-caveolin-1 expressing 
A2780 cells were seeded in 3D CDM and imaged by spinning disk confocal microscopy after 6 hours. (L) 
Raichu-RhoA in osmotic shock. (M) Left: Control or RhoA knockdown cells were seeded into 3D CDM and 
imaged by spinning disk confocal microscopy after 4 hours. Single z-slice stills from movies are shown 300s 
apart. Centre: Forward movement of control and RhoA knockdown cells over a 5 minute timelapse. N>54 
cells per condition across 3 repeats. Right: RhoA knockdown efficiency in A2780 cells. (N) Control, ROCK1 or 
ROCK2 knockdown cells were seeded into 3D CDM and fixed after 4 hours. F-actin was visualized using SiR-
actin and confocal imaging. MIPs are shown. (O) A2780 cells were seeded into 3D CDM and treated with 
Y27632 (10 µM) for 2 hours before fixation. F-actin (phalloidin) was visualized by confocal microscopy, MIPs 
shown. (P) Left: Speed of migration of A2780 cells in 3D CDM over 16 hour timelapse was analysed in control, 
ROCK1, ROCK2 and ROCK1+2 knockdown cells. N=90 cells analysed per condition across 3 repeats. Right: 
Efficiency of ROCK1 and ROCK2 knockdown in A2780 cells. (Q) Top left: Speed of migration of A2780 cells in 
3D CDM over 16 hour timelapse was analysed in control, PKN1, PKN2 and PKN3 knockdown cells N=90 cells 
analysed per condition across 3 repeats. Top right: Effect of PKN2 knockdown on architecture of F-actin at 
the rear of A2780 cells migrating in 3D CDM (representative high resolution MIP shown). Bottom left:  
Efficiency of PKN1, PKN2 and PKN3 knockdown in A2780 cells, assessed using a pan-pPKN antibody. 
Quantification of blots from 3 independent experiments shown in graph. Bottom right: Efficiency of PKN2 
knockdown in A2780 cells, assessed using a PKN2 specific antibody. ****, p<0.0001; *, p<0.05. 
Figure S5: Systematic identification of GEFs activating RhoA at the cell rear 
(A) Quantification of average speed of control, Ect2, Vav2, ARHGEF2, DOCK1, ELMO2 and PLEKHG5 A2780 
cells in long-term (16h) migration in 3D CDM, N>60 cells per condition across 3 repeats, dashed line indicates 
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control mean. (B) Quantification of cell length ~20h after spreading for cells is in (A), N>60 cells per condition 
across 3 repeats. (C) Quantification of average speed of control and 2 individual Ect2 oligo knockdown A2780 
cells, N=30 cells analysed per condition across 2 repeats. (D) Representative single control and Ect2 
knockdown cells migrating in 3D CDM over 150 minutes. (E) Quantification of rear / front peak F-actin staining 
intensity of control, and Ect2 knockdown cells (individual oligos). (F) Efficiency of knockdown of Ect2, Vav2, 
ARHGEF2, DOCK1, ELMO2 and PLEKHG5 in A2780 cells. (G) Knockdown of Ect2 with individual siRNA oligos; 
#5 and #7 were used in subsequent experiments. ****, p<0.0001; *, p<0.05. 
Figure S6: Model outputs are robust to wide parameter value ranges.  
(A) Summary parameter sensitivity analysis showing normalised effect of all rates in the model on the rear 
retraction output. Parameters which have > 0.02 positive scaled effect on rear retraction are shown in green, 
parameters which have < 0.02 negative scaled effect shown in red, while all other parameters with less drastic 
effects are represented by the blue bars. (B) Range of rear retraction temporal dynamics given halving and 
doubling of the 9 most influential rates in the model (6 positive regulators in green, 3 negative regulators in 
red) showing general model outputs are robust to even large parameter alterations. 
Figure S7: Effect of RhoA knockdown and CytoD on caveolae localization.  
(A) Control and RhoA knockdown A2780 cells expressing mCherry-caveolin-1 were seeded into 3D CDM and 
imaged by spinning disk confocal microscopy after 4 hours. Single z-slice stills from movies are shown 300s 
apart. (B) Intensity of mCherry-caveolin-1 at the rear of cells as in (A) N=76 cells per condition across 3 
repeats. (C) Control and RhoA knockdown cells were seeded into 3D CDM and fixed after 4 hours. 
Endogenous F-actin, caveolin-1 and cavin-1 were visualized, representative MIPs shown. (D) High resolution 
images of endogenous cavin-1 at the rear of control and RhoA knockdown A2780 cells migrating in 3D CDM 
as in (C). (E) Quantification of the average rear/front cavin-1 intensity ratio of control and individual oligo 
Ect2 knockdown A2780 cells. (F) A2780 cells expressing Lifeact-EGFP and mCherry-caveolin-1 were seeded in 
3D CDM for 4 hours before and imaging in the presence of 2M CytoD. (G) Caged CytoD is a photoactivatable 
derivative of the potent actin disruptor Cytochalasin D (CytoD), which possesses nitroveratryloxycarbonyl 
(Nvoc) photoremovable group located at the bioactive hydroxyl group of CytoD. The Nvoc group inhibits the 
binding activity of CytoD, which can be restored upon photolysis reaction with light exposure under 
microscopy setups. Upon light exposure, caged CytoD enables dosed delivery of CytoD in living cells at time 
scale of seconds and with subcellular resolution. (H) A2780 cells expressing Lifeact-GFP and mCherry-
caveolin-1 were seeded onto 3D CDM and imaged after 4 hours in the absence of caged-CytoD before and 
after photomanipulation of a specific region behind the cell rear (indicated by yellow box, as in Figure 6G). 
****, p<0.0001. 
 
Supplementary Movie Legends 
Movie S1: (Part I) A2780 cell expressing mEmerald-Lifeact migrating in 3D CDM over 10 minutes, with a 
Red-hot LUT applied. (Part II) A2780 cell expressing mEmerald-Lifeact migrating for 5 minutes in a non-
uniform CDM with a (trypsinised) softened region to the left and the unperturbed stiffer region to the right. 
(Part III) A2780 cell expressing mEmerald-Lifeact migrating from soft (left) to stiff (right) on a gradient poly-
acrylamide gel for 10 minutes. 
Movie S2: A2780 cell expressing farnesyl-EGFP (GFP membrane) migrating in CDM over 5 minutes. 
Movie S3: Single representative A2780, H1299, typical MEF, rapid MEF, typical TIF and rapid TIF migrating 
over 2 hours in CDM. 
Movie S4: A2780 cell expressing mCherry-caveolin-1 (magenta) and mEmerald-Lifeact (green) imaged prior 
to fixation and processing for CLEM (see Figure S2P). 
Movie S5: A2780 cell expressing Cherry-Cav-1 migrating in CDM in isotonic medium for 10 minutes, then 
subjected to osmotic shock for 10 minutes before medium reversion to isotonic conditions for a further 10 
minutes. 
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Movie S6: A2780 cell expressing Cherry-Cav-1, migrating in CDM untreated for  5 minutes, then treated 
with Y-27632 and imaged for a further 60 minutes.  
Movie S7: A2780 cell expressing Cherry-Cav-1 (magenta) and eGFP-Lifeact (green) migrating in CDM 
treated with ‘caged’ Cytochalasin-D which is photo-activated at t = 30s within the yellow box region. 
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